TW200944553A - Liquid-crystal alignment material and liquid-crystal display element - Google Patents

Liquid-crystal alignment material and liquid-crystal display element Download PDF

Info

Publication number
TW200944553A
TW200944553A TW98103105A TW98103105A TW200944553A TW 200944553 A TW200944553 A TW 200944553A TW 98103105 A TW98103105 A TW 98103105A TW 98103105 A TW98103105 A TW 98103105A TW 200944553 A TW200944553 A TW 200944553A
Authority
TW
Taiwan
Prior art keywords
liquid crystal
formula
crystal alignment
alignment agent
integer
Prior art date
Application number
TW98103105A
Other languages
Chinese (zh)
Other versions
TWI444407B (en
Inventor
Kohei Goto
Noritoshi Miki
Koji Sonoyama
Kazuyoshi Hosaka
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of TW200944553A publication Critical patent/TW200944553A/en
Application granted granted Critical
Publication of TWI444407B publication Critical patent/TWI444407B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1042Copolyimides derived from at least two different tetracarboxylic compounds or two different diamino compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1046Polyimides containing oxygen in the form of ether bonds in the main chain
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1046Polyimides containing oxygen in the form of ether bonds in the main chain
    • C08G73/105Polyimides containing oxygen in the form of ether bonds in the main chain with oxygen only in the diamino moiety
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1075Partially aromatic polyimides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1075Partially aromatic polyimides
    • C08G73/1078Partially aromatic polyimides wholly aromatic in the diamino moiety

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nonlinear Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Liquid Crystal (AREA)
  • Materials Engineering (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Mathematical Physics (AREA)
  • Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)

Abstract

A liquid-crystal alignment material is provided which can diminish the liquid-crystal orientation unevenness which occurs in the ODF mode. Also provided is a liquid-crystal display element reduced in display unevenness attributable to the liquid-crystal orientation unevenness occurring in the ODF mode. The liquid-crystal alignment material comprises a polymer obtained by reacting a tetracarboxylic dianhydride ingredient comprising a tetracarboxylic dianhydride represented by the following formula [1] with a diamine ingredient comprising a diamine compound having a carboxy or hydroxy group in the molecule. (Chemical formula 1) [1] (In the formula [1], Y1 is a C4-15 tetravalent organic group and contains a C4-8 nonaromatic cyclic hydrocarbon group.)

Description

200944553 六、發明說明: 【發明所屬之技術領域】 本發明係關於製作液晶配向膜時所使用的液 及使用其之液晶顯示元件。 【先前技術】 現在,作爲液晶顯示元件,有在於電極上形 Φ 配向膜的2片的電極基板之間,具有正的介電各 向列液晶的長軸係由一方的基板朝向另一方的基 扭轉90°之所謂的扭曲向列(TN)型液晶顯示元 . 單側的基板使電極形成梳齒狀,藉由使電場發生 基板面的横方向而驅動液晶之平面轉換(IPS) 示元件。此外,此等以外,亦開發使具有負的介 性之向列液晶相對於基板面垂直地配向之垂直 液晶顯示元件。此等的液晶顯示元件所使用的液 β ’主要是使用聚醯亞胺系的液晶配向膜,開發各 聚醯亞胺系配向膜(例如參考專利文獻1 )。 液晶顯示元件的製作,必須具有於形成有液 的基板2片之間(晶胞間隙),塡充液晶之步驟 止’液晶塡充係利用大氣壓與真空的壓力差,於 板間塡充液晶之真空注入方式爲一般作法。惟, ’因爲液晶注入口僅設置於基板的單側,爲了於 爲3至5 μπι的基板間塡充液晶,因爲需要長的 液晶顯示元件的製造步驟難以簡略化。這點,特 晶配向劑 成有液晶 向異性之 板連續地 件,或於 於相對於 型液晶顯 電各向異 (VA )型 晶配向膜 種結構的 晶配向膜 。目前爲 2片的基 此方式時 晶胞間隙 時間,故 別是在於 -5- 200944553 近年已實用化的液晶TV或大型監視器的製造上成爲大問 題。 因此,爲了解決上述的真空注入方式中的問題點,開 發了液晶滴下方式(ODF方式)。此方式係於形成有液晶 配向膜的基板上滴下液晶,於真空中與另一片的基板貼合 · 後,藉由使密封材進行UV硬化,而塡充液晶之方式。 . 另一方面,隨著液晶顯示元件的高精細化的深入化, 變得必須抑制顯示不均勻。 0 於液晶滴下方式,可藉由如使液晶的滴下量減少或貼 合時的真空度提昇等之減輕吸附水或雜質的影響的製造步 驟最適化而解決。惟,液晶顯示元件製造線隨著大型化, . 目前爲止的製造步驟的最適化則變得無法抑制顯示不均勻 ,故尋求比先前技術更可減輕配向不均勻之液晶配向膜。 [專利文獻1]特開平1 1 -249148號公報 【發明內容】 〇 [發明所欲解決之課題] ODF方式,因爲將液晶滴下於直接配向膜上,液晶滴 下時對配向膜造成物理性的壓力,或於面板全區域塡充液 ‘ 晶之必要上,故必須塡加液晶的滴下點。因此,於液晶滴 . 下部或液晶的液滴與鄰接的液滴所連接的部分,發生滴下 痕跡或格子不均勻之所謂的配向不均勻,將其作爲液晶顯 示元件時,會有配向不均勻所起起的顯示不均勻發生的問 題。認爲此配向不均勻,係形成於基板上的液晶配向膜表 -6- 200944553 面上所附著的吸附水或雜質,因爲於ODF步驟中被滴下 的液晶而被集中,因此液晶滴下部或液晶的液滴彼此連接 的部分之吸附水或雜質的量不同而發生。 本發明係鑑於上述的事情而完成。亦即本發明所欲解 決之課題,係提供可減輕以ODF方式所發生的液晶配向 不均勻之液晶配向劑。且,本發明係提供減輕以ODF方 式所發生的液晶配向不均勻所引起的顯示不均勻之液晶顯 瘳 示元件。 [用以解決課題之手段] 本發明者係爲了達成上述的目的進行精心硏究,結果 發現達成此目的之液晶配向劑。本發明係基於該相關的見 解,具有以下的要旨。 (1 ) 一種液晶配向劑,其係含有使含有下述式[1 ]所表示 的四羧酸二酐之四羧酸二酐成分、與含有分子內具有羧基 © 或羥基的二胺化合物之二胺成分進行反應而得到的聚合物 [化1]BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a liquid used in the production of a liquid crystal alignment film and a liquid crystal display element using the same. [Prior Art] As a liquid crystal display element, there are two electrode substrates in which an Φ alignment film is formed on an electrode, and a long axis of a positive dielectric nematic liquid crystal is directed from one substrate to the other. A so-called twisted nematic (TN) type liquid crystal display element which is twisted by 90°. The substrate on one side forms a comb-tooth shape of the electrode, and drives a planar conversion (IPS) element of the liquid crystal by causing an electric field to generate a lateral direction of the substrate surface. Further, in addition to these, a vertical liquid crystal display element in which a nematic liquid crystal having a negative dielectric is aligned perpendicularly to the substrate surface has been developed. The liquid β ′ used in the liquid crystal display elements is mainly a polyimine-based liquid crystal alignment film, and various polyimide-based alignment films have been developed (for example, refer to Patent Document 1). The liquid crystal display element must be fabricated between the two sheets of the substrate on which the liquid is formed (cell gap), and the step of filling the liquid crystal. The liquid crystal charging system utilizes the pressure difference between the atmospheric pressure and the vacuum to fill the liquid crystal between the boards. Vacuum injection is a common practice. However, since the liquid crystal injection port is provided only on one side of the substrate, in order to charge the liquid crystal between the substrates of 3 to 5 μm, it is difficult to simplify the manufacturing steps of the liquid crystal display element. In this case, the special alignment agent is formed into a continuous layer of liquid crystal to the opposite polarity, or a crystal alignment film having a structure of an isotropic (VA) type alignment film with respect to the liquid crystal. At present, it is a cell gap time in the case of two films, so it is a problem in the manufacture of liquid crystal TVs or large monitors which have been put into practical use in recent years. Therefore, in order to solve the above problems in the vacuum injection method, a liquid crystal dropping method (ODF method) has been developed. In this method, liquid crystal is dropped on a substrate on which a liquid crystal alignment film is formed, and is bonded to another substrate in a vacuum. Thereafter, the sealing material is UV-cured to fill the liquid crystal. On the other hand, as the high definition of the liquid crystal display element is deepened, it becomes necessary to suppress display unevenness. The liquid crystal dropping method can be solved by optimizing the manufacturing steps such as reducing the amount of dripping of the liquid crystal or increasing the degree of vacuum at the time of bonding to reduce the influence of adsorbed water or impurities. However, as the liquid crystal display element manufacturing line has become larger, the optimization of the manufacturing steps so far has become impossible to suppress display unevenness, and thus it has been desired to reduce the alignment unevenness of the liquid crystal alignment film more than the prior art. [Patent Document 1] Japanese Laid-Open Patent Publication No. Hei No. Hei No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. 1-249148. SUMMARY OF THE INVENTION [The object of the invention] The ODF method causes physical stress on the alignment film when the liquid crystal is dropped by dropping the liquid crystal on the direct alignment film. Or, in the entire area of the panel, it is necessary to fill the liquid crystal, so it is necessary to add the drop point of the liquid crystal. Therefore, in the lower portion of the liquid crystal droplets or the portion where the droplets of the liquid crystal are connected to the adjacent droplets, so-called alignment unevenness occurs in which the dropping trace or the lattice is uneven, and when it is used as a liquid crystal display element, uneven alignment occurs. The rise of the display shows uneven problems. It is considered that the alignment is uneven, and the adsorbed water or impurities adhering to the surface of the liquid crystal alignment film formed on the substrate on the surface of the liquid crystal alignment film -6-200944553 are concentrated due to the liquid crystal dropped in the ODF step, so that the liquid crystal drops or the liquid crystal The droplets are connected to each other in a portion where the amount of adsorbed water or impurities is different. The present invention has been made in view of the above. That is, the problem to be solved by the present invention is to provide a liquid crystal alignment agent which can reduce the unevenness of liquid crystal alignment which occurs in the ODF method. Further, the present invention provides a liquid crystal display element which reduces display unevenness caused by uneven alignment of liquid crystals which occurs in the ODF mode. [Means for Solving the Problem] The inventors of the present invention conducted intensive studies to achieve the above object, and as a result, found a liquid crystal alignment agent which achieves the object. The present invention has the following gist based on this related knowledge. (1) A liquid crystal alignment agent containing a tetracarboxylic dianhydride component containing a tetracarboxylic dianhydride represented by the following formula [1] and a diamine compound having a carboxyl group or a hydroxyl group in the molecule. A polymer obtained by reacting an amine component [Chemical Formula 1]

[1] (式[1]中,Υι係具有碳數4至8的非芳香族環狀結構之 碳數4至15的4價的有機基)。 (2 )如上述(1 )所記載之液晶配向劑,其係式[1 ]中, 200944553[1] (In the formula [1], Υι is a tetravalent organic group having a carbon number of 4 to 15 having a non-aromatic cyclic structure of 4 to 8 carbon atoms). (2) The liquid crystal alignment agent according to (1) above, wherein the formula [1], 200944553

Yl係具有由下述式[2]至式[1 1]所選出的結構。 [化2]The Yl system has a structure selected from the following formula [2] to the formula [1 1]. [Chemical 2]

/ —、 丫3丫5 [2]/ —, 丫3丫5 [2]

[8] 文允瓜xxrc [3] [4] [5] [6] [7][8] Wen Yun melon xxrc [3] [4] [5] [6] [7]

(式[2]中,γ2至γ5各自獨立地爲由氫原子、甲基、氯原 子及苯環所選出的基’各自可相同或相異’式[8]中,Υ6 及Υ7各自獨立地爲氫原子、或甲基,各自可相同或相異(In the formula [2], γ2 to γ5 are each independently a group selected from a hydrogen atom, a methyl group, a chlorine atom and a benzene ring, and each of them may be the same or different in the formula [8], and Υ6 and Υ7 are each independently Is a hydrogen atom or a methyl group, each of which may be the same or different

-8 - 200944553 向劑,其中具有羧基之二胺化合物,爲下述式[12]所表示 的二胺化合物’ [化3] (COOH)n [12] nh2 (式[12]中,Xi係具有碳數6至30的芳香族環之有機基 〇 ,11爲1至4的整數)。 (9)如上述(8)所gg載之液晶配向劑,其中式[I】]的二 胺化合物’係由下述式[13]至式[17]所選出的二胺化合物-8 - 200944553, a diamine compound having a carboxyl group, which is a diamine compound represented by the following formula [12] [Chemical Formula 3] (COOH)n [12] nh2 (In the formula [12], the Xi system An organic hydrazine having an aromatic ring having 6 to 30 carbon atoms, and 11 is an integer of 1 to 4). (9) A liquid crystal alignment agent according to the above (8), wherein the diamine compound of the formula [I] is a diamine compound selected from the following formula [13] to formula [17].

[化4][Chemical 4]

式[13]中,ml爲1至4的整數;式[14]中,χ2爲單鍵、_ CH2- ' -C2H4- ' -C(CH3)2- ' -CF2- ' -C(CF3)2- ' -〇- ' _C〇-、-NH-、_N(CH3)_、-CONH- ' -NHC〇-、_ch2〇-、 -OCH2- ' -COO- ' -OCO- ' -CON(CH3)-^ -N(CH3)CO- > m2 及m3各自表示0至4的整數’且m2 + m3表示1至4的整 數;式[15]中’ ιη4及m5各自爲1至5的整數;式[16]中 -9- 200944553 ,X3爲碳數1至5的直鏈或支鏈烷基’ m6爲1至5的整 數;式[17]中 ’ X4 爲單鍵、-CH2-、-c2h4-、-c(ch3)2-、 -cf2-、-c(cf3)2-、-o-、-co-、-nh-、-n(ch3)-、-c〇nh- 、-NHCO- ' -CH20-、-OCH2-、-COO-、-OCO-、 -0:〇1^((:113)-或-:^((:113)(:〇-,1117爲1至4的整數)。 (1 0 )如上述(9 )所記載之液晶配向劑,其中式[1 3]中 ,ml爲1至2的整數。 (1 1 )如上述(9 )所記載之液晶配向劑,其中式[1 4]中 @ ,x2 爲單鍵、-CH2-、-C2H4-、-C(CH3)2-、-〇-、-CO-、 -NH-、-N(CH3)-、-CONH-、-NHCO-、-COO-或-OCO-, m2及m3皆爲1的整數。 (1 2 )如上述(9 )所記載之液晶配向劑,其中式[1 7]中 ,X4 爲單鍵、-CH2·、-0-、-CO-、-NH-、-CONH-、 •NHCO-、-CH20-、-OCH2-、-COO-或-OCO-,m7 爲 1 至 2 的整數。 (13)如上述(1)至上述(12)中任一項所記載之液晶 0 配向劑,其中具有羧基或羥基之二胺化合物,爲二胺成分 中的5至1〇〇莫耳%。 (14 )如上述(1 )至上述(1 3 )中任一項所記載之液晶 · 配向劑,其中液晶配向劑所含有的溶劑中之5至80質量 %爲弱溶劑。 (1 5 )如上述(1 )至上述(14 )中任一項所記載之液晶 配向劑,其中液晶配向劑中之聚合物係使聚醯胺酸進行脫 水閉環而得到的聚醯亞胺。 -10- 200944553 (16) —種液晶配向膜,其係使用上述(1 )中任一項所記載之液晶配向劑而得到。 (17) —種液晶顯示元件,其係具有上述( 液晶配向膜。 [發明的效果} 本發明的液晶配向劑可用比較簡便的方 〇 ,本發明的液晶配向劑,係可得到可減輕以 發生的液晶配向不均勻之液晶配向膜。具有 晶配向劑所得到的液晶配向膜之液晶顯示元 優異者,可適用於大畫面且高精細的液晶電 [實施發明之最佳形態] 本發明係關於含有使含有式π]所表示 四羧酸二酐(以下,亦稱爲特定酸二酐)之 ® 分、與含有分子內具有.錢基或羥基之特定二 下,亦稱爲特定二胺化合物)之二胺成分進 的聚合物之液晶配向劑、使用該液晶配向劑 配向膜、且具有該液晶配向膜之液晶顯示元 '本發明的液晶配向劑所含有的聚合物, 定酸二酐與具有極性高的羧基或羥基之特定 由含有如此的聚合物之液晶配向劑所得到的 係於液晶配向膜表面易吸附吸附水或雜質之 液晶被滴下時,可抑制附著於液晶配向膜表 )至上述(15 1 6 )所記載之 法得到。此外 Ο D F方式所 由本發明的液 件,爲信賴性 視等。 的特定結構的 四羧酸二酐成 胺化合物(以 行反應而得到 而得到的液晶 件。 係原料使用特 二胺化合物。 液晶配向膜, ODF步驟中 面之吸附水或 -11 - 200944553 雜質被集中,可減輕伴隨此所產生的顯示不均勻。 藉此,由本發明的液晶配向劑所得到的液晶配向膜’ 係可得到具有以〇 D F方式所發生的液晶配向不均勻不會 發生的高顯示品質之液晶顯示元件。 本發明所使用的聚合物,係使含有特定酸二酐之四羧 酸二酐成分、與含有特定二胺化合物之二胺成分進行反應 得 而 環 水 脫 行 進 酸。 胺物 醯合 聚聚 述的 貧 S 使一 及少 、 至 酸的 胺中 醯胺 聚亞 的醯 到聚 得的 而到 © <四羧酸二酐成分> 本發明所使用的四羧酸二酐成分,係含有式[1 ]所表 示的四羧酸二酐,亦即,特定酸二酐者,可併用特定酸二 酐以外的四羧酸二酐。四羧酸二酐成分爲由特定酸二酐所 成的群所選出的至少一種的化合物時,因爲可使本發明達 成的效果更爲顯著而較佳。 〇 [特定酸二酐] 本發明所使用的特定酸二酐,係下述式[1]所表示的 四羧酸二酐。 [化5]In the formula [13], ml is an integer of 1 to 4; in the formula [14], χ2 is a single bond, _CH2- '-C2H4-'-C(CH3)2-'-CF2-'-C(CF3) 2- ' -〇- ' _C〇-, -NH-, _N(CH3)_, -CONH- ' -NHC〇-, _ch2〇-, -OCH2- ' -COO- ' -OCO- ' -CON(CH3 -^ -N(CH3)CO- > m2 and m3 each represent an integer '0 to 4' and m2 + m3 represents an integer of 1 to 4; in the formula [15], 'ιη4 and m5 are each an integer of 1 to 5 In the formula [16], 9-200944553, X3 is a linear or branched alkyl group having a carbon number of 1 to 5, and m6 is an integer of 1 to 5; in the formula [17], 'X4 is a single bond, -CH2-, -c2h4-, -c(ch3)2-, -cf2-, -c(cf3)2-, -o-, -co-, -nh-, -n(ch3)-, -c〇nh-, - NHCO- ' -CH20-, -OCH2-, -COO-, -OCO-, -0:〇1^((:113)- or -:^((:113)(:〇-,1117 is 1 to 4 (1) The liquid crystal alignment agent according to the above (9), wherein in the formula [13], ml is an integer of 1 to 2. (1 1 ) The liquid crystal alignment as described in the above (9) In the formula [14], @, x2 is a single bond, -CH2-, -C2H4-, -C(CH3)2-, -〇-, -CO-, -NH-, -N(CH3)- , -CONH-, -NHCO-, -COO- or -OCO-, m2 and m3 are all integers of 1. (1) The liquid crystal alignment agent according to the above (9), wherein, in the formula [17], X4 is a single bond, -CH2., -0-, -CO-, -NH-, -CONH-, The liquid crystal 0 alignment described in any one of the above (1) to (12), wherein the NHCO-, -CH20-, -OCH2-, -COO- or -OCO-, m7 is an integer of 1 to 2. The liquid crystal according to any one of the above (1) to (1), wherein the liquid crystal has a hydroxyl group or a hydroxyl group. The liquid crystal alignment agent according to any one of the above (1) to (14), wherein the liquid crystal alignment agent is a liquid crystal alignment agent, wherein the solvent is contained in the solvent of the liquid crystal alignment agent. The polymer in the agent is a polyimine obtained by dehydration ring-closure of poly-proline. -10-200944553 (16) A liquid crystal alignment film using the liquid crystal according to any one of (1) above. Obtained by an alignment agent. (17) A liquid crystal display element having the above (liquid crystal alignment film. [Effect of the invention] The liquid crystal alignment agent of the present invention can be used in a relatively simple manner, and the liquid crystal alignment agent of the present invention can be reduced to occur. The liquid crystal display element having a liquid crystal alignment film obtained by a crystal alignment agent is excellent in liquid crystal display elements, and is applicable to a large-screen and high-definition liquid crystal. [Best Mode for Carrying Out the Invention] The present invention relates to Containing a component containing a tetracarboxylic dianhydride represented by the formula π] (hereinafter, also referred to as a specific acid dianhydride), and a specific component having a hydroxyl group or a hydroxyl group in the molecule, which is also referred to as a specific diamine compound. a liquid crystal alignment agent of a polymer into which the diamine component is added, a liquid crystal display element using the liquid crystal alignment film, and a polymer contained in the liquid crystal alignment agent of the present invention, a fixed acid dianhydride and When a liquid crystal having a high polarity of a carboxyl group or a hydroxyl group is obtained by a liquid crystal alignment agent containing such a polymer, a liquid crystal which is adsorbed on the surface of the liquid crystal alignment film and adsorbs water or impurities is dripped, It can be suppressed by adhering to the liquid crystal alignment film table to the method described in the above (15 1 6). Further, the liquid material of the present invention is the reliability of the liquid material of the present invention. The specific structure of the tetracarboxylic dianhydride to form an amine compound (a liquid crystal obtained by a reaction. The raw material uses a special diamine compound. The liquid crystal alignment film, the adsorbed water in the ODF step or the -11 - 200944553 impurity is Concentration, the display unevenness caused by this can be alleviated. Thereby, the liquid crystal alignment film obtained by the liquid crystal alignment agent of the present invention can obtain a high display which does not occur in the liquid crystal alignment unevenness which occurs in the 〇DF method. A liquid crystal display element of the present invention. The polymer used in the present invention is obtained by reacting a tetracarboxylic dianhydride component containing a specific acid dianhydride with a diamine component containing a specific diamine compound to obtain a cyclic water-dehydrating acid. The poor S of the polycondensation of the hydrazine of the hydrazine of the hydrazine of the acid to the amine of the acid to the amine <tetracarboxylic dianhydride component > tetracarboxylic acid used in the present invention The dianhydride component contains a tetracarboxylic dianhydride represented by the formula [1], that is, a specific acid dianhydride, and a tetracarboxylic dianhydride other than the specific acid dianhydride may be used in combination. specific When at least one compound selected from the group consisting of acid dianhydrides is preferred, the effect achieved by the present invention can be made more remarkable. 〇[Specific acid dianhydride] The specific acid dianhydride used in the present invention is The tetracarboxylic dianhydride represented by the formula [1].

式Π]中’ Y,係具有碳數4至8的非芳香族環狀結構 -12- 200944553 (脂環式結構)之碳數4至15,較佳爲4至12的4價之 有機基。 式[1]中’若具體地列舉Υι,可列舉下述式[2]至式[11] 之基。 [化6] Υ2|4'Y, a non-aromatic cyclic structure having a carbon number of 4 to 8-12-200944553 (alicyclic structure) having a carbon number of 4 to 15, preferably 4 to 12, a tetravalent organic group . In the formula [1], specific examples of Υι include the following formulas [2] to [11]. [Chemical 6] Υ 2|4

Υ3 Ϋ5Υ3 Ϋ5

[2] [3] [4][2] [3] [4]

式[2]中,Y2至Ys各自獨立地爲由氫原子 '甲基、氯 原子及苯環所選出的基,各自可相同或相異;式[8]中, Υ6、Υ7各自獨立地爲氫原子、或甲基,各自可相同或相 異。 式[1 ]中,Υ !之特別佳的結構,由聚合反應性或合成 的容易度而言,爲式[2]、式[4]、式[5]、式[7]或式[8]。 以上所例示的特定酸二酐’可倂用1種或2種以上。 [其他四羧酸二酐] 本發明中,在不損及本發明的效果的限制下,可倂用 特定酸二酐以外的其他四羧酸二酐作爲四羧酸二酐成分。 其具體例子列舉如Τ述° -13- 200944553 可列舉例如均苯四甲酸二酐、2,3,6,7 -萘四羧酸二酐 、1,2,5,6-萘四羧酸二酐、萘四羧酸二酐、2,3,6,7-蒽四羧酸二酐、1,2,5,6 -蒽四羧酸二酐、3,3’,4,4’ -聯苯四 羧酸二酐、2,3,3,,4-聯苯四羧酸二酐、雙(3,4_二羧基苯 基)醚、3,3’,4,4,-二苯甲酮四羧酸二酐、雙(3,4-二竣基 苯基)楓、雙(3,4-二羧基苯基)甲烷、2,2·雙(3,4_二 .In the formula [2], Y2 to Ys are each independently a group selected from a hydrogen atom 'methyl group, a chlorine atom and a benzene ring, and each may be the same or different; in the formula [8], Υ6 and Υ7 are each independently The hydrogen atom or the methyl group may each be the same or different. In the formula [1], a particularly preferable structure is a formula [2], a formula [4], a formula [5], a formula [7] or a formula [8] in terms of polymerization reactivity or ease of synthesis. ]. The specific acid dianhydrides exemplified above may be used alone or in combination of two or more. [Other tetracarboxylic dianhydride] In the present invention, other tetracarboxylic dianhydrides other than the specific acid dianhydride may be used as the tetracarboxylic dianhydride component without impairing the effects of the present invention. Specific examples thereof include, for example, a description of -13-200944553, for example, pyromellitic dianhydride, 2,3,6,7-naphthalenetetracarboxylic dianhydride, 1,2,5,6-naphthalenetetracarboxylic acid Anhydride, naphthalene tetracarboxylic dianhydride, 2,3,6,7-nonanetetracarboxylic dianhydride, 1,2,5,6-nonanedicarboxylic dianhydride, 3,3',4,4'-linked Pyromellitic dianhydride, 2,3,3,4-diphenyltetracarboxylic dianhydride, bis(3,4-dicarboxyphenyl)ether, 3,3',4,4,-diphenyl Ketotetracarboxylic dianhydride, bis(3,4-dimercaptophenyl) maple, bis(3,4-dicarboxyphenyl)methane, 2,2·bis (3,4_di.

羧基苯基)丙烷、1,1,1,3,3,3-六氟-2,2-雙(3,4-二羧基苯 基)丙烷、雙(3,4 -二羧基苯基)二甲基矽烷、雙(3,4- Q 二羧基苯基)二苯基矽烷、2,3,4,5-吡啶四羧酸二酐、2,6-雙(3,4-二羧基苯基)吡啶、3,3,,4,4’-二苯基楓四羧酸二 酐、3,4,9,10-茈四羧酸二酐等。 以上所例示的其他酸二酐,因應製成液晶配向膜時的 液晶配向性、電壓保持特性、蓄積電荷等之特性,可倂用 1種或2種以上。 〈二胺化合物&gt; © 本發明所使用的二胺化合物,係含有分子內具有羧基 或羥基之二胺化合物,亦即,特定二胺化合物者,可倂用 特定二胺化合物以外的二胺化合物,亦即,其他的二胺化 ‘ 合物。二胺化合物爲由特定二胺化合物所成的群所選出的 至少一種的化合物時,因爲可使本發明達成的效果更爲顯 著而較佳。 [特定二胺化合物] -14- 200944553 本發明的特定二胺化合物’係分子內具有羧基或羥基 之二胺化合物。 分子內具有羧基之二胺化合物’其具體的結構並沒有特 別的限制,但較佳係下述式[1 2 ]所表示的化合物。 [化7] ❿ (COOH)Carboxyphenyl)propane, 1,1,1,3,3,3-hexafluoro-2,2-bis(3,4-dicarboxyphenyl)propane, bis(3,4-dicarboxyphenyl)di Methyl decane, bis(3,4-Q-dicarboxyphenyl)diphenyl decane, 2,3,4,5-pyridinetetracarboxylic dianhydride, 2,6-bis(3,4-dicarboxyphenyl) Pyridine, 3,3,,4,4'-diphenyl maple tetracarboxylic dianhydride, 3,4,9,10-decanetetracarboxylic dianhydride, and the like. The other acid dianhydrides exemplified above may be used alone or in combination of two or more kinds depending on the characteristics of the liquid crystal alignment property, the voltage holding property, and the charge accumulation when the liquid crystal alignment film is formed. <Diamine compound> The diamine compound used in the present invention contains a diamine compound having a carboxyl group or a hydroxyl group in the molecule, that is, a specific diamine compound, and a diamine compound other than the specific diamine compound may be used. That is, other diamined compounds. When the diamine compound is at least one compound selected from the group consisting of specific diamine compounds, the effect achieved by the present invention can be made more remarkable and preferable. [Specific diamine compound] -14- 200944553 The specific diamine compound of the present invention is a diamine compound having a carboxyl group or a hydroxyl group in the molecule. The specific structure of the diamine compound having a carboxyl group in the molecule is not particularly limited, but is preferably a compound represented by the following formula [1 2 ]. [Chemical 7] ❿ (COOH)

[12] 式[12]中,Χι係具有碳數6至30的芳香族環之有機 基,η爲1至4的整數。 較佳的X!,係式[12a]所表示,碳數爲6至30,且任 意的氫原子中的1至4個被羧基取代的結構。 [化8][12] In the formula [12], Χι is an organic group having an aromatic ring having 6 to 30 carbon atoms, and η is an integer of 1 to 4. Desirable X!, represented by the formula [12a], has a carbon number of 6 to 30 and a structure in which 1 to 4 of any hydrogen atom is substituted by a carboxyl group. [化8]

Cl 2 a] 式[12a]中,g爲0至2的整數,Q表示單鍵、醚鍵、 羰基、羧基、胺基、醯胺鍵或碳數1至11的伸烷基,此 等的任意的氫原子可被氟原子或甲基取代。 較佳的化合物,可列舉下述式[13]至式[17]的化合物 -15- 200944553 [化9] NH2 (COOH)m3H2Nx3^COOH)m1 H2NX^X2'Oi_NH2 (fc〇OH)m2 [14]Cl 2 a] In the formula [12a], g is an integer of 0 to 2, and Q represents a single bond, an ether bond, a carbonyl group, a carboxyl group, an amine group, a guanamine bond or an alkylene group having 1 to 11 carbon atoms, etc. Any hydrogen atom may be substituted by a fluorine atom or a methyl group. Preferred compounds include compounds of the following formulas [13] to [17] -15- 200944553 [Chemical 9] NH2 (COOH) m3H2Nx3^COOH) m1 H2NX^X2'Oi_NH2 (fc〇OH) m2 [14 ]

[13][13]

Η2Ν0^〇^〇^ (^〇〇H)m7Η2Ν0^〇^〇^ (^〇〇H)m7

Cl 7] 式[13]中,ml爲1至4的整數;式[14]中,X2爲單Cl 7] In the formula [13], ml is an integer from 1 to 4; in the formula [14], X2 is a single

鍵、-CH2_、-C2H4_、-C(CH3)2_、-CF2_、-C(CF3)2_、-0-、-CO-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-CH20-、Key, -CH2_, -C2H4_, -C(CH3)2_, -CF2_, -C(CF3)2_, -0-, -CO-, -NH-, -N(CH3)-, -CONH-, -NHCO -, -CH20-,

-OCH2-、-COO-、-OCO-、-CON(CH3)-或-N(CH3)CO-,m2 及m3各自表示0至4的整數,且m2 + m3表示1至4的整 數;式[15]中,m4及m5各自爲1至5的整數;式[16]中 ,X3爲碳數1至5的直鏈或支鏈烷基,m6爲1至5的整 數;式[17]中,X4 爲單鍵、-CH2-、-C2H4-、-C(CH3)2-、 -CF2-、-C(CF3)2-、-〇_、-CO-、_NH-、_N(CH3)_、-CONH_ 、-NHCO-、-CH20-、-0CH2-、-COO-、-OCO-、 -CON(CH3)·或-N(CH3)CO-,m7 爲 1 至 4 的整數。 較佳係式[1 3 ]中,m 1爲1至2的整數二胺化合物; 式[14]中,X2 爲單鍵、_〇1^2-、-(:2114-、-(:((:113)2-、-0-、-CO-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-COO-或 _OCO-’ m2及m3皆爲1的整數之二胺化合物;式[17]中 ’ X4 爲單鍵、-CH2-、-0-、-CO-、-NH-、-CONH-、 -NHCO-、_CH2〇-、_0Ch2-、_C00_ 或 _0C0·,m7 爲 i 至 2 的整數之二胺化合物。 -16- 200944553 式[13]至式[17]所表示的二胺化合物之中,較佳的具 體例子,可列舉下述式[18]至式[28]的二胺化合物。 參-OCH2-, -COO-, -OCO-, -CON(CH3)- or -N(CH3)CO-, m2 and m3 each represent an integer from 0 to 4, and m2 + m3 represents an integer from 1 to 4; In [15], m4 and m5 are each an integer of 1 to 5; in the formula [16], X3 is a linear or branched alkyl group having 1 to 5 carbon atoms, and m6 is an integer of 1 to 5; Where X4 is a single bond, -CH2-, -C2H4-, -C(CH3)2-, -CF2-, -C(CF3)2-, -〇_, -CO-, _NH-, _N(CH3) _, -CONH_, -NHCO-, -CH20-, -0CH2-, -COO-, -OCO-, -CON(CH3). or -N(CH3)CO-, m7 is an integer from 1 to 4. In the preferred formula [13], m 1 is an integer diamine compound of 1 to 2; in the formula [14], X2 is a single bond, _〇1^2-, -(:2114-, -(: ((:113)2-, -0-, -CO-, -NH-, -N(CH3)-, -CONH-, -NHCO-, -COO- or _OCO-' m2 and m3 are all 1 An integer diamine compound; in the formula [17], 'X4 is a single bond, -CH2-, -0-, -CO-, -NH-, -CONH-, -NHCO-, _CH2〇-, _0Ch2-, _C00_ or _0C0·, m7 is an integer diamine compound of i to 2. -16- 200944553 Among the diamine compounds represented by the formula [13] to the formula [17], preferred specific examples include the following formula [ 18] to the diamine compound of the formula [28].

H2NH2N

[19][19]

ΟΟΗ JH2 [2 0]ΟΟΗ JH2 [2 0]

η2νη〇- ch2ch2cooh h2 h2n^^cooh χχΗ2νη〇- ch2ch2cooh h2 h2n^^cooh χχ

ch2ch2cooh ' η2Ch2ch2cooh ' η2

ch2ch2cooh [2 6] [化 11]Ch2ch2cooh [2 6] [Chem. 11]

NH2 H2NNH2 H2N

ΪΟΟΗ COOH Φ [27] [28]ΪΟΟΗ COOH Φ [27] [28]

式[27]中,X5 爲單鍵、-CH2-、-0-、-CO-、-NH-、 CONH-、-NHCO-、-CH2O-、-〇CH2-、-COO-或-OCO 式[28]中,X6 爲單鍵、-CH2-、-0-、-CO-、-NH-、 -CONH-、-NHCO-、-CH2O-、-OCH2-、-COO-或-OCO-。 分子內具有羥基之二胺化合物,其具體的結構並沒有 特別的限制,但較佳的化合物’可列舉下述式[2 9 ]至式 [3 3 ]的化合物。 -17- 200944553 [化 12]In the formula [27], X5 is a single bond, -CH2-, -0-, -CO-, -NH-, CONH-, -NHCO-, -CH2O-, -〇CH2-, -COO- or -OCO In [28], X6 is a single bond, -CH2-, -0-, -CO-, -NH-, -CONH-, -NHCO-, -CH2O-, -OCH2-, -COO- or -OCO-. The specific structure of the diamine compound having a hydroxyl group in the molecule is not particularly limited, and a preferred compound 'is a compound of the following formula [2 9 ] to formula [3 3 ]. -17- 200944553 [Chem. 12]

式[2 9]中,m8爲1至4的整數;式[30]中,X7爲單 鍵、-(^2-、-€2114-、-(:((:113)2-、-0[2-、-&lt;:(€?3)2-、-0-、-CO-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-CH20-、 -OCH2-、-COO-、-OCO-、-CON(CH3)-或、-N(CH3)CO-, m9及mlO各自表示〇至4的整數,且m9 + ml0表示1至 4的整數;式[31]中,mil及ml2各自爲1至5的整數; 式[32]中’ X8爲碳數1至5的直鏈或支鏈烷基,ml3爲1 至5的整數;式[33]中,χ9爲單鍵、-CH2-、-C2H4-、 -C(CH3)2-、-CF2-、-C(CF3)2-、-Ο-、-CO-、-NH-、 -N(CH3)-、-CONH-、-NHCO-、-CH20-、-OCH2-、-COO-、-OCO-、-CON(CH3)-或-N(CH3)CO-,ml4 爲 1 至 4 的整 數。 較佳係式[29]中,m8爲1至2的整數二胺化合物; 式[30]中 ’ X7 爲單鍵、-(:112-、-(:2114-、-(:((:1€3)2-、-〇-、-CO-、-NH-、-N(CH3)·、-CONH-、-NHCO-、-COO-或 -OCO-’ m9及mlO皆爲1的整數之二胺化合物;式[33]中 ,X9 爲單鍵、-CH2-、-0-、-C0-、-NH-、-C0NH-、-NHCO-、-CH20-、-〇CH2-、-COO-或-OCO-,ml4 爲 1 至 -18- 200944553 2的整數之二胺化合物。 式[29]至式[33]所表示的二胺化合物之中,較佳的具 體例子’可列舉下述式[34]至式[44]的二胺化合物。 [化 13]In the formula [2 9], m8 is an integer of 1 to 4; in the formula [30], X7 is a single bond, -(^2-, -22114-, -(:((:113)2-, -0) [2-, -&lt;:(€?3)2-, -0-, -CO-, -NH-, -N(CH3)-, -CONH-, -NHCO-, -CH20-, -OCH2- , -COO-, -OCO-, -CON(CH3)- or -N(CH3)CO-, m9 and mlO each represent an integer from 〇4, and m9 + ml0 represents an integer from 1 to 4; Wherein mil and ml2 are each an integer of 1 to 5; in the formula [32], X8 is a linear or branched alkyl group having 1 to 5 carbon atoms, and ml3 is an integer of 1 to 5; in the formula [33], Χ9 is a single bond, -CH2-, -C2H4-, -C(CH3)2-, -CF2-, -C(CF3)2-, -Ο-, -CO-, -NH-, -N(CH3) -, -CONH-, -NHCO-, -CH20-, -OCH2-, -COO-, -OCO-, -CON(CH3)- or -N(CH3)CO-, ml4 is an integer from 1 to 4. In the preferred formula [29], m8 is an integer diamine compound of 1 to 2; in the formula [30], 'X7 is a single bond, -(:112-, -(:2114-, -(:((:1) €3) 2-, -〇-, -CO-, -NH-, -N(CH3)·, -CONH-, -NHCO-, -COO- or -OCO-' m9 and mlO are all integers of 1. a diamine compound; in the formula [33], X9 is a single bond, -CH2-, -0-, -C0-, -NH-, -CONH-, -NHCO-, -CH20- And 〇CH2-, -COO- or -OCO-, and ml4 is an integer diamine compound of 1 to -18-200944553 2. Among the diamine compounds represented by the formula [29] to the formula [33], preferably Specific examples of the 'diamine compound of the following formula [34] to formula [44] can be cited.

CH2CH2OH [3 8] CH2CH2OH HzN-Q- -〇-nh2 H2N^p^NH2 HzN^^H2 HzN [34] [35]CH2CH2OH [3 8] CH2CH2OH HzN-Q- -〇-nh2 H2N^p^NH2 HzN^^H2 HzN [34] [35]

〇tp&quot;H2 [化 14] [4 1] ch2ch2oh [4 2] h2n〇tp&quot;H2 [化14] [4 1] ch2ch2oh [4 2] h2n

[4 3] [44][4 3] [44]

式[43]中,X,。爲單鍵、-CH2·、-0-、-CO-、-NH-、 -CONH-、-NHCO-、-CH20-、-〇CH2-、-COO-或-OCO-; 式[44]中,又^爲單鍵、-CH2-、-0-、-CO-、-NH-、 -CONH-、_NHCO-、-CH2O-、-OCH〗-、-COO --0CO-。 以上所例示的特定二胺化合物,可倂用1種或2種以 上。 [其他的二胺化合物] 本發明中,在不損及本發明的效果的限制下,可倂用 特定二胺化合物以外的其他二胺化合物作爲二胺成分。其 具體例子列舉如下述。 -19- 200944553 例如P-苯撐二胺、2,3,5,6-四甲基-p-苯撐二胺、2,5-二甲基-P-苯撐二胺、m-苯撐二胺、2,4-二甲基-m-苯撐二 胺、2,5-二胺基甲苯、2,6-二胺基甲苯、4,4’-二胺基聯苯 、3,3’-二甲基-4,4’-二胺基聯苯、3,3’-甲氧基-4,4’-二胺 基聯苯、3,3’-二氟-4,4’-聯苯、3,3’-三氟甲基-4,4’-二胺 基聯苯、3,4’-二胺基聯苯、3,3’-二胺基聯苯、2,2’-二胺 基聯苯、2,3’ -二胺基聯苯、4,4二胺基二苯基甲烷、 3,3’-二胺基二苯基甲烷、3,4’-二胺基二苯基甲烷、2,2’-二胺基二苯基甲烷、2,3’-二胺基二苯基甲烷、4,4’-二胺 基二苯基醚、3,3’-二胺基二苯基醚、3,4’-二胺基二苯基 醚、2,2’ -二胺基二苯基醚、2,3’ -二胺基二苯基醚、4,4’-磺醯基二苯胺、3,3’-磺醯基二苯胺、雙(4-胺基苯基)矽 烷、雙(3-胺基苯基)矽烷、二甲基-雙(4_胺基苯基) 矽烷、二甲基-雙(3-胺基苯基)矽烷、4,4’-硫代二苯胺 、3,3’-硫代二苯胺、4,4’-二胺基二苯基胺、3,3’-二胺基 二苯基胺、3,4’-二胺基二苯基胺、2,2’-二胺基二苯基胺 、2,3’-二胺基二苯基胺、N -甲基(4,4’·二胺基二苯基) 胺、N-甲基(3,3’-二胺基二苯基)胺、N-甲基(3,4’-二 胺基二苯基)胺、N-甲基(2,2’-二胺基二苯基)胺、N-甲基(2,3’_二胺基二苯基)胺、4,4’-二胺基二苯甲酮、 3,3’-二胺基二苯甲酮、3,4’-二胺基二苯甲酮、1,4-二胺基 萘、2,2’-二胺基二苯甲酮、2,3’-二胺基二苯甲酮、1,5-二 胺基萘、1,6 -二胺基萘、1,7 -二胺基萘、1,8 -二胺基萘、 2,5 -二胺基萘、2,6 -二胺基萘、2,7-二胺基萘、2,8-二胺基 -20- 200944553 萘、1,2-雙(4-胺基苯基)乙烷、1,2-雙(3-胺基苯基) 乙烷、1,3-雙(4-胺基苯基)丙烷、1,3-雙(3-胺基苯基 )丙烷、1,4-雙(4胺基苯基)丁烷、1,4-雙(3-胺基苯基 )丁烷、雙(3,5-二乙基-4-胺基苯基)甲烷、1,4-雙(4-' 胺基苯氧基)苯、1,3-雙(4-胺基苯氧基)苯、1,4-雙( 4-胺基苯基)苯、1,3-雙(4-胺基苯基)苯、1,4-雙(4-胺 基苄基)苯、1,3-雙(4-胺基苯氧基)苯、4,4’-[1,4-苯撐 φ 雙(甲撐)]二苯胺、4,4’-[1,3-苯撐雙(甲撐)]二苯胺、 3,4’-[1,4-苯撐雙(甲撐)]二苯胺、3,4’-[1,3-苯撐雙(甲 撐)]二苯胺、3,3’-[1,4-苯撐雙(甲撐)]二苯胺、3,3’-[1,3-苯撐雙(甲撐)]二苯胺、1,4-苯撐雙[(4-胺基苯基 )甲酮]、1,4-苯撐雙[(3-胺基苯基)甲酮]、1,3-苯撐雙[ (4-胺基苯基)甲嗣]、1,3-苯撐雙[(3-胺基苯基)甲酮] 、1,4-苯撐雙(4-胺基苯甲酸酯)、1,4-苯撐雙(3-胺基 苯甲酸酯)、1,3-苯撐雙(4-胺基苯甲酸酯)、1,3-苯撐 © 雙(3-胺基苯甲酸酯)、雙(4-胺基苯基)對苯二甲酸、 雙(3-胺基苯基)對苯二甲酸、雙(4-胺基苯基)間苯二 甲酸、雙(3-胺基苯基)間苯二甲酸、N,N’- ( 1,4-苯撐) 雙(4-胺基苯醯胺)、&gt;^,&gt;^’-(1,3-苯撐)雙(4-胺基苯醯 胺)、Ν,Ν’- ( 1,4-苯撐)雙(3-胺基苯醯胺)、Ν,Ν’-( 1,3-苯撐)雙(3-胺基苯醯胺)、Ν,Ν’-雙(4-胺基苯基) 對苯二甲酸醯胺、Ν,Ν’-雙(3-胺基苯基)對苯二甲酸醯 胺、Ν,Ν’-雙(4-胺基苯基)間苯二甲酸醯胺、Ν,Ν’-雙( 3-胺基苯基)間苯二甲酸醯胺、9,10-雙(4-胺基苯基)蒽 -21 - 200944553 、4,4’-雙(4-胺基苯氧基)二苯基颯、2,2’-雙[4-(4-胺 基苯氧基)苯基]丙烷、2,2’-雙[4- (4-胺基苯氧基)苯基] 六氟丙烷、2,2’-雙(4-胺基苯基)六氟丙烷、2,2’-雙(3-胺基苯基)六氟丙烷、2,2’-雙(3-胺基-4-甲基苯基)六 氟丙烷、2,2’-雙(4-胺基苯基)丙烷、2,2’-雙(3-胺基苯 基)丙烷、2,2’-雙(3-胺基-4-甲基苯基)丙烷、1,3-雙( 4-胺基苯氧基)丙烷、1,3-雙(3-胺基苯氧基)丙烷、 1,4-雙(4-胺基苯氧基)丁烷、1,4-雙(3-胺基苯氧基) 丁烷、1,5-雙(4-胺基苯氧基)戊烷、1,5-雙(3-胺基苯 氧基)戊烷、1,6-雙(4-胺基苯氧基)己烷、1,6-雙(3-胺基苯氧基)己烷、1,7-雙(4-胺基苯氧基)庚烷、1,7-(3-胺基苯氧基)庚烷、1,8-雙(4-胺基苯氧基)辛烷、 1,8-雙(3-胺基苯氧基)辛烷、1,9-雙(4-胺基苯氧基) 壬烷、1,9-雙(3-胺基苯氧基)壬烷、1,10- (4_胺基苯氧 基)癸烷、1,〗〇-(3 -胺基苯氧基)癸烷、1,11- (4 -胺基 苯氧基)十一烷、1,11- (3-胺基苯氧基)十一烷、1,12-(4-胺基苯氧基)十二烷、1,12-(3-胺基苯氧基)十二烷 。雙(4-胺基環己基)甲烷、雙(4-胺基-3-甲基環己基) 甲烷、1,3-二胺基丙烷、1,4-二胺基丁烷、1,5-二胺基戊 烷、1,6-二胺基己烷、1,7-二胺基庚烷、1,8-二胺基辛烷 、1,9-二胺基壬烷、1,10-二胺基癸烷、1,1 1-二胺基十一 烷、1,12-二胺基十二烷等。 此外,可列舉二胺側鏈具有烷基、含氟的烷基、芳香 環、脂肪族環、雜環、及由此等所成的大環狀取代物之二 -22- 200944553 胺,具體而言,可列舉下述式[DA1]至式[DA26]所表示的 二胺。 [化 15]In the formula [43], X,. Is a single bond, -CH2·, -0-, -CO-, -NH-, -CONH-, -NHCO-, -CH20-, -〇CH2-, -COO- or -OCO-; in formula [44] And ^ is a single bond, -CH2-, -0-, -CO-, -NH-, -CONH-, _NHCO-, -CH2O-, -OCH--, -COO-0CO-. The specific diamine compound exemplified above may be used singly or in combination of two or more. [Other diamine compounds] In the present invention, other diamine compounds other than the specific diamine compound may be used as the diamine component without impairing the effects of the present invention. Specific examples thereof are as follows. -19- 200944553 For example, P-phenylenediamine, 2,3,5,6-tetramethyl-p-phenylenediamine, 2,5-dimethyl-P-phenylenediamine, m-phenylene Diamine, 2,4-dimethyl-m-phenylenediamine, 2,5-diaminotoluene, 2,6-diaminotoluene, 4,4'-diaminobiphenyl, 3,3 '-Dimethyl-4,4'-diaminobiphenyl, 3,3'-methoxy-4,4'-diaminobiphenyl, 3,3'-difluoro-4,4'- Biphenyl, 3,3'-trifluoromethyl-4,4'-diaminobiphenyl, 3,4'-diaminobiphenyl, 3,3'-diaminobiphenyl, 2,2' -diaminobiphenyl, 2,3'-diaminobiphenyl, 4,4 diaminodiphenylmethane, 3,3'-diaminodiphenylmethane, 3,4'-diamino Diphenylmethane, 2,2'-diaminodiphenylmethane, 2,3'-diaminodiphenylmethane, 4,4'-diaminodiphenyl ether, 3,3'-di Aminodiphenyl ether, 3,4'-diaminodiphenyl ether, 2,2'-diaminodiphenyl ether, 2,3'-diaminodiphenyl ether, 4,4' - sulfonyldiphenylamine, 3,3'-sulfonyldiphenylamine, bis(4-aminophenyl)decane, bis(3-aminophenyl)decane, dimethyl-bis(4-amino Phenyl) decane, dimethyl-bis (3- Aminophenyl)decane, 4,4'-thiodiphenylamine, 3,3'-thiodiphenylamine, 4,4'-diaminodiphenylamine, 3,3'-diaminodiphenyl Amine, 3,4'-diaminodiphenylamine, 2,2'-diaminodiphenylamine, 2,3'-diaminodiphenylamine, N-methyl (4,4 '·Diaminodiphenyl)amine, N-methyl(3,3′-diaminodiphenyl)amine, N-methyl(3,4′-diaminodiphenyl)amine, N -methyl(2,2'-diaminodiphenyl)amine, N-methyl(2,3'-diaminodiphenyl)amine, 4,4'-diaminobenzophenone, 3,3'-diaminobenzophenone, 3,4'-diaminobenzophenone, 1,4-diaminonaphthalene, 2,2'-diaminobenzophenone, 2, 3'-Diaminobenzophenone, 1,5-diaminonaphthalene, 1,6-diaminonaphthalene, 1,7-diaminonaphthalene, 1,8-diaminonaphthalene, 2,5 -diaminonaphthalene, 2,6-diaminonaphthalene, 2,7-diaminonaphthalene, 2,8-diamino-20-200944553 naphthalene, 1,2-bis(4-aminophenyl) Ethane, 1,2-bis(3-aminophenyl)ethane, 1,3-bis(4-aminophenyl)propane, 1,3-bis(3-aminophenyl)propane, 1 , 4-bis(4-aminophenyl) , 1,4-bis(3-aminophenyl)butane, bis(3,5-diethyl-4-aminophenyl)methane, 1,4-bis(4-'aminophenoxy) Benzene, 1,3-bis(4-aminophenoxy)benzene, 1,4-bis(4-aminophenyl)benzene, 1,3-bis(4-aminophenyl)benzene, 1 , 4-bis(4-aminobenzyl)benzene, 1,3-bis(4-aminophenoxy)benzene, 4,4'-[1,4-phenylene φ bis(methylene)] Aniline, 4,4'-[1,3-phenylenebis(methylene)]diphenylamine, 3,4'-[1,4-phenylenebis(methylene)]diphenylamine, 3,4'-[ 1,3-Benzene bis(methylene)]diphenylamine, 3,3'-[1,4-phenylenebis(methylene)]diphenylamine, 3,3'-[1,3-phenylene double ( Methyl)]diphenylamine, 1,4-phenylenebis[(4-aminophenyl)methanone], 1,4-phenylenebis[(3-aminophenyl)methanone], 1,3 -Benzene bis[(4-aminophenyl)formamidine], 1,3-phenylenebis[(3-aminophenyl)methanone], 1,4-phenylenebis(4-aminobenzene) Formate), 1,4-phenylenebis(3-aminobenzoate), 1,3-phenylenebis(4-aminobenzoate), 1,3-phenylene© double 3-amino benzoate), bis(4-aminophenyl)terephthalic acid, bis(3-aminophenyl) Terephthalic acid, bis(4-aminophenyl)isophthalic acid, bis(3-aminophenyl)isophthalic acid, N,N'-(1,4-phenylene)bis (4- Aminobenzoguanamine), &gt;^,&gt;^'-(1,3-phenylene)bis(4-aminophenylguanamine), hydrazine, Ν'-(1,4-phenylene) bis ( 3-aminophenyl phthalamide), hydrazine, Ν'-(1,3-phenylene) bis(3-aminophenylguanamine), hydrazine, Ν'-bis(4-aminophenyl)-p-phenylene Ammonium formate, hydrazine, Ν'-bis(3-aminophenyl)phthalic acid decylamine, hydrazine, Ν'-bis(4-aminophenyl)isophthalic acid decylamine, hydrazine, hydrazine - bis(3-aminophenyl)isophthalic acid decylamine, 9,10-bis(4-aminophenyl)phosphonium-21 - 200944553, 4,4'-bis(4-aminophenoxyl) Diphenyl hydrazine, 2,2'-bis[4-(4-aminophenoxy)phenyl]propane, 2,2'-bis[4-(4-aminophenoxy)phenyl] Hexafluoropropane, 2,2'-bis(4-aminophenyl)hexafluoropropane, 2,2'-bis(3-aminophenyl)hexafluoropropane, 2,2'-bis(3-amine 4-methylphenyl)hexafluoropropane, 2,2'-bis(4-aminophenyl)propane, 2,2'-bis(3-aminophenyl)propane, 2,2'- (3-Amino-4-methylphenyl)propane, 1,3-bis(4-aminophenoxy)propane, 1,3-bis(3-aminophenoxy)propane, 1,4 - bis(4-aminophenoxy)butane, 1,4-bis(3-aminophenoxy)butane, 1,5-bis(4-aminophenoxy)pentane, 1, 5-bis(3-aminophenoxy)pentane, 1,6-bis(4-aminophenoxy)hexane, 1,6-bis(3-aminophenoxy)hexane, 1 , 7-bis(4-aminophenoxy)heptane, 1,7-(3-aminophenoxy)heptane, 1,8-bis(4-aminophenoxy)octane, 1 , 8-bis(3-aminophenoxy)octane, 1,9-bis(4-aminophenoxy)decane, 1,9-bis(3-aminophenoxy)decane, 1,10-(4-aminophenoxy)decane, 1, 〇-(3-aminophenoxy)decane, 1,11-(4-aminophenoxy)undecane, 1,11-(3-Aminophenoxy)undecane, 1,12-(4-aminophenoxy)dodecane, 1,12-(3-aminophenoxy)dodecane . Bis(4-Aminocyclohexyl)methane, bis(4-amino-3-methylcyclohexyl)methane, 1,3-diaminopropane, 1,4-diaminobutane, 1,5- Diaminopentane, 1,6-diaminohexane, 1,7-diaminoheptane, 1,8-diaminooctane, 1,9-diaminodecane, 1,10- Diamino decane, 1,1 1-diaminoundecane, 1,12-diaminododecane, and the like. Further, examples of the diamine side chain include an alkyl group, a fluorine-containing alkyl group, an aromatic ring, an aliphatic ring, a hetero ring, and a macrocyclic substituent which is formed by the above, and the second-22-200944553 amine, specifically In other words, a diamine represented by the following formula [DA1] to formula [DA26] can be mentioned. [化15]

[DAI] [DA2] CDA3] [DA4] [DA5] 式[DA1]至式[DA5]中,I爲碳數1以上22以下的烷基或 含氟的烷基。[DAI] [DA2] CDA3] [DA4] [DA5] In the formula [DA1] to the formula [DA5], I is an alkyl group having 1 or more and 22 or less carbon atoms or a fluorine-containing alkyl group.

[化 16][Chemistry 16]

[DA8] [DA9] 式[DA6]至式[DA9]中 ’ R2 表不-COO-、-OCO-、-CONH-、-NHCO-、-CH2-、-〇-、-CO-或-NH-,R3 表示碳 數1以上22以下的烷基或含氟的烷基。 -23- 200944553 [化 17][DA8] [DA9] From the formula [DA6] to the formula [DA9], 'R2 is not -COO-, -OCO-, -CONH-, -NHCO-, -CH2-, -〇-, -CO- or -NH -R3 represents an alkyl group having 1 or more and 22 or less carbon atoms or a fluorine-containing alkyl group. -23- 200944553 [Chem. 17]

[DAI 0] [DAI 1] 式[DA10]及式[DA11]中,R4 表示-0-、-OCH2-、 _CH2〇-、-C00CH2-或- CH2OCO-,R5 爲碳數 1 以上 22 γ的烷基、烷氧基、含氟的烷基或含氟的烷氧基。 [化!8][DAI 0] [DAI 1] In the formula [DA10] and the formula [DA11], R4 represents -0-, -OCH2-, _CH2〇-, -C00CH2- or -CH2OCO-, and R5 is a carbon number of 1 or more and 22 γ. An alkyl group, an alkoxy group, a fluorine-containing alkyl group or a fluorine-containing alkoxy group. [化!8]

[DA 12] [DA 13] [DAI 4] 式[DA12]至式[DA14]中,R6 表示-COO-、-OCO-、 c〇NH-、-NHCO-、-COOCH2-、-CH2OCO-、-CH20-、 _〇CH2-或-CH2-,R7爲碳數1以上22以下的烷基、烷 含氟的烷基或含氟的烷氧基。 [似9][DA 12] [DA 13] [DAI 4] In the formula [DA12] to the formula [DA14], R6 represents -COO-, -OCO-, c〇NH-, -NHCO-, -COOCH2-, -CH2OCO-, -CH20-, _〇CH2- or -CH2-, and R7 is an alkyl group having 1 or more and 22 or less carbon atoms, an alkyl group having an alkyl group or a fluorine-containing alkoxy group. [like 9]

式[DA15]及式[DA16]中,R8 表示-COO·、-OCO-、 c〇NH- ' -NHCO- &gt; -COOCH2- ' -CH2OCO- ' -CH2O- ' -24- 200944553 -OCH2-、-CH2-、-Ο-、或-NH-,R9 爲氧基、氰基、三氟 甲烷基、硝基、偶氮基、甲醯基、乙醯基、乙醯氧基或羥 基。 〇 [化 20] 〇In the formula [DA15] and the formula [DA16], R8 represents -COO·, -OCO-, c〇NH- '-NHCO- &gt; -COOCH2- ' -CH2OCO- ' -CH2O- ' -24- 200944553 -OCH2- , -CH2-, -Ο-, or -NH-, R9 is oxy, cyano, trifluoromethyl, nitro, azo, indolyl, ethionyl, ethoxylated or hydroxy. 〇 [Chem. 20] 〇

Η2Νχ^ νη7Η2Νχ^ νη7

❿ [化 21]❿ [Chem. 21]

[化 22] -25 200944553[化22] -25 200944553

且,亦可列舉如下述式[DA27]所表示的二胺基矽氧院 等。 [化 23]Further, a diamine-based oxime house represented by the following formula [DA27] may also be mentioned. [Chem. 23]

H2N-(CH2)3H2N-(CH2)3

ch3 I Si—(CH2)3—NH2 CHa [DA2 7] 式[DA27]中,m爲1至10的整數。 以上所例示的其他二胺化合物,依製成液晶配向膜時 的液晶配向性、電壓保持特性、蓄積電荷等之特性,可倂 用1種或2種以上。 &lt;聚合物&gt; 本發明所使用的聚合物係聚醯胺酸及聚醯亞胺中的至 少一種的聚合物。此聚醯胺酸,係藉由含有特定酸二酐之 四羧酸二酐成分與含有特定二胺化合物之二胺成分的反應 而得到的聚醯胺酸。然後,聚醯亞胺係使前述的聚醯胺酸 進行脫水閉環而得到的聚醯亞胺。該相關的聚醯胺酸及聚 醯亞胺,皆適合作爲得到液晶配向膜用的聚合物。 本發明中,二胺成分中的特定二胺化合物的含量愈多 ,於液晶配向膜表面易吸附吸附水或雜質之ODF步驟中 -26- 200944553 液晶被滴下時,愈可抑制附著於液晶配向膜表面之吸附水 或雜質被集中。 因此,二胺成分中之特定二胺化合物的含量,較佳爲 5莫耳%至1 00莫耳%。更佳爲1 〇莫耳%至丨〇〇莫耳%, 再更佳爲1 0莫耳%至80莫耳% ’最佳爲20莫耳%至80 • 吴耳%。 此外’四羧酸二酐成分中之特定酸二酐的含量,較佳 ❹ 爲5莫耳%至100莫耳%。更佳爲1〇莫耳%至丨〇〇莫耳% ’再更佳爲20莫耳1%至1〇〇莫耳%,最佳爲50莫耳%至 1 〇 〇莫耳%。 [聚合物的製造方法] 本發明所使用的聚醯胺酸,可使用習知的聚合方法。 一般而言’係使四羧酸二酐成分與二胺化合物在有機溶劑 中進行反應之方法。四羧酸二酐與二胺化合物的反應,於 ® 有機溶劑中比較容易進行,且由副生成物不會生成之觀點 而言有利。 此時所使用的有機溶劑’只要是所生成的聚醯胺酸溶 解者即可’並沒有特別的限制。其具體例子列舉如下述。 例如N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N_甲 基-2-D比咯烷酮、N -甲基己內醯胺、二甲基亞颯、四甲基 尿素、吡陡、二甲基颯、六甲基亞颯、丁內醋、異丙 醇、甲氧基甲基戊醇、雙戊烯、乙基戊基酮、甲基壬基酮 '甲基乙基酮、甲基異戊基酮、甲基異丙基酮 '甲基溶纖 -27- 200944553Ch3 I Si—(CH 2 ) 3 —NH 2 CHa [DA 2 7] In the formula [DA27], m is an integer of 1 to 10. The other diamine compound exemplified above may be used alone or in combination of two or more kinds depending on the characteristics of the liquid crystal alignment property, the voltage holding property, and the charge accumulated in the liquid crystal alignment film. &lt;Polymer&gt; The polymer used in the present invention is a polymer of at least one of polyamine and polyimine. The polyamic acid is a polylysine obtained by a reaction of a tetracarboxylic dianhydride component containing a specific acid dianhydride with a diamine component containing a specific diamine compound. Then, the polyimine is a polyimine obtained by subjecting the above polyamic acid to dehydration ring closure. The related polylysine and polyimine are suitable as polymers for obtaining a liquid crystal alignment film. In the present invention, the content of the specific diamine compound in the diamine component is increased, and the ODF step of adsorbing water or impurities on the surface of the liquid crystal alignment film is -26-200944553. When the liquid crystal is dropped, the adhesion to the liquid crystal alignment film can be suppressed. The adsorbed water or impurities on the surface are concentrated. Therefore, the content of the specific diamine compound in the diamine component is preferably from 5 mol% to 100 mol%. More preferably, it is from 1% to 5% by mole, more preferably from 10% to 80% by mole, and most preferably from 20% to 80% by volume. Further, the content of the specific acid dianhydride in the tetracarboxylic dianhydride component is preferably from 5 mol% to 100 mol%. More preferably, it is from 1% by mole to 丨〇〇% by mole, and even more preferably from 20% by mole to 1% by mole, most preferably from 50% by mole to 1% by mole. [Method for Producing Polymer] The polyglycine used in the present invention can be a known polymerization method. In general, a method of reacting a tetracarboxylic dianhydride component with a diamine compound in an organic solvent. The reaction of the tetracarboxylic dianhydride with the diamine compound is relatively easy to carry out in the ® organic solvent, and is advantageous from the viewpoint that by-products are not formed. The organic solvent used in this case is not particularly limited as long as it is a polylysine dissolved. Specific examples thereof are as follows. For example, N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-D pyrrolidone, N-methylcaprolactam, dimethyl hydrazine , tetramethyl urea, pyridox, dimethyl hydrazine, hexamethylarylene, butyl vinegar, isopropanol, methoxymethylpentanol, dipentene, ethyl amyl ketone, methyl fluorenyl Ketone 'methyl ethyl ketone, methyl isoamyl ketone, methyl isopropyl ketone 'methyl lysis fiber -27- 200944553

劑、乙基溶纖劑、甲基溶纖劑乙酸酯、乙基溶纖劑乙酸酯 、丁基卡必醇、乙基卡必醇、乙二醇、乙二醇單乙酸酯、 乙二醇單異丙基醚、乙二醇單丁基醚、丙二醇、丙二醇單 乙酸酯、丙二醇單甲基醚、丙二醇-tert-丁基醚、二丙二 醇單甲基醚、二乙二醇、二乙二醇單乙酸酯、二乙二醇二 甲基醚、二丙二醇單乙酸酯單甲基醚、二丙二醇單甲基醚 、二丙二醇單乙基醚、二丙二醇單乙酸酯單乙基醚、二丙 二醇單丙基醚、二丙二醇單乙酸酯單丙基醚、3-甲基_3_ 甲氧基丁基乙酸酯、三丙二醇甲基醚、3 -甲基-3-甲氧基 丁醇、二異丙基醚、乙基異丁基醚、二異丁烯、戊基乙酸 酯、丁基丁酸酯、丁基醚、二異丁基酮、甲基環己烯、丙 基醚、二己基醚、二噁烷、η-己烷、η-戊烷、η-辛烷、二 乙基醚、環己酮、乙烯碳酸酯、丙烯碳酸酯、乳酸甲酯、 乳酸乙酯、乙酸甲酯、乙酸乙酯、乙酸η-丁酯、乙酸丙 二醇單乙基醚、丙酮酸甲酯、丙酮酸乙酯、3-甲氧基丙酸Agent, ethyl cellosolve, methyl cellosolve acetate, ethyl cellosolve acetate, butyl carbitol, ethyl carbitol, ethylene glycol, ethylene glycol monoacetate, Ethylene glycol monoisopropyl ether, ethylene glycol monobutyl ether, propylene glycol, propylene glycol monoacetate, propylene glycol monomethyl ether, propylene glycol-tert-butyl ether, dipropylene glycol monomethyl ether, diethylene glycol , diethylene glycol monoacetate, diethylene glycol dimethyl ether, dipropylene glycol monoacetate monomethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol monoacetate Monoethyl ether, dipropylene glycol monopropyl ether, dipropylene glycol monoacetate monopropyl ether, 3-methyl-3-methoxybutyl acetate, tripropylene glycol methyl ether, 3-methyl-3 -methoxybutanol, diisopropyl ether, ethyl isobutyl ether, diisobutylene, pentyl acetate, butyl butyrate, butyl ether, diisobutyl ketone, methylcyclohexene , propyl ether, dihexyl ether, dioxane, η-hexane, η-pentane, η-octane, diethyl ether, cyclohexanone, ethylene carbonate, propylene carbonate, methyl lactate, lactic acid Ethyl ester, acetic acid , Ethyl acetate, butyl acetate, η-, propylene glycol monoethyl ether acetate, methyl pyruvate, ethyl pyruvate, 3-methoxy propionic acid

甲酯、3-乙氧基丙酸甲酯乙基、3-甲氧基丙酸乙酯、3-乙 氧基丙酸、3-甲氧基丙酸、3-甲氧基丙酸丙酯、3-甲氧基 丙酸丁基、二-甘醇二甲醚、4-羥基-4-甲基-2-戊酮等。此 等可單獨使用,亦可混合後使用。而且,即使爲不溶解聚 醯胺酸的溶劑,只要在不析出所生成的聚醯胺酸的範圍, 可混合於上述溶劑中使用。此外,因爲有機溶劑中的水分 阻礙聚合反應,而且爲使所生成的聚醯胺酸水解的原因, 故有機溶劑係儘可能使用經脫水乾燥者較佳。 作爲使四羧酸二酐與二胺化合物於有機溶劑中進行反 -28- 200944553 應之方法,可列舉攪拌使二胺化合物分散或溶解於有機溶 劑的溶液,直接添加四羧酸二酐,或分散或溶解於有機溶 劑後添加之方法;相反地於使四羧酸二酐分散或溶解於有 機溶劑的溶液中添加二胺化合物之方法;交互地添加四羧 ' 酸二酐與二胺化合物之方法等,可爲此等的任一種方法。 • 此外,四羧酸二酐或二胺化合物爲由複數種的化合物所成 時,可使其以預先經混合的狀態進行反應,可使其個別順 〇 序反應,且爲使個別地經反應的低分子量體進行混合反應 的高分子量體亦可。 上述的聚醯胺酸合成時的溫度爲可選擇-20°C至150 °C的任意溫度,但較佳爲-5 °C至100 °C的範圍。此外,反 應可以任意的濃度進行,但因爲濃度太低則難以得到高分 子量的聚合物,濃度太高則反應液的黏性變得太高而均勻 攪拌變困難’四羧酸二酐與二胺成分的反應溶液中之合計 濃度,較佳爲1至5 0質量%,更佳爲5至3 0質量%。反 β 應初期以高濃度進行,然後,可追加有機溶劑。 聚醯胺酸的合成反應中,二胺成分的莫耳數相對於四 羧酸二酐成分的莫耳數之比爲0.8至1.2較佳。通常的聚 縮合反應同樣’此莫耳比愈接近1.0,所生成的聚醯胺酸 的分子量愈大。 本發明所使用的聚醯亞胺係使前述的聚醯胺酸進行脫 水閉環而得到的聚醯亞胺,適合作爲得到液晶配向膜用的 聚合物。 本發明所使用的聚醯亞胺中,醯胺酸基的脫水閉環率 -29- 200944553 (醯亞胺化率),並不一定必須爲1 00%,可依其用途或 目的而任意地調整使用。 作爲使聚醯胺酸醯亞胺化的方法,可列舉使聚醯胺酸 的溶液直接加熱之熱醯亞胺化、於聚醯胺酸的溶液中添加 觸媒之觸媒醯亞胺化。 使聚醯胺酸於溶液中熱醯亞胺化時的溫度,爲100°c 至400°C,較佳爲120°c至25(rc,一邊將醯亞胺化反應 所生成的水排除至系統外一邊進行較佳。 φ 聚醯胺酸的觸媒醯亞胺化,可於聚醯胺酸的溶液中, 添加鹼性觸媒與酸酐,藉由以-2 0至2 5 0 °C,較佳爲以〇 至180 °C攪拌進行。鹼性觸媒的量係醯胺酸基的〇.5至30 莫耳倍’較佳爲2至20莫耳倍,酸酐的量係醯胺酸基的 1至50莫耳倍,較佳爲3至30莫耳倍。 作爲鹼性觸媒,可列舉吡啶、三乙基胺、三甲基胺、 三丁基胺、三辛基胺等,其中又以吡啶因爲具有使反應進 行所需的適度鹼性而較佳。作爲酸酐,可列舉乙酸酐、偏 ◎ 苯三酸酐、均苯四甲酸酐等,其中又以使用乙酸酐,因爲 反應結束後的純化變容易而較佳。觸媒醯亞胺化之醯亞胺 化率’可藉由調節觸媒量與反應溫度、反應時間而控制。 · 本發明的聚醯亞胺中,醯胺酸基的脫水閉環率(醯亞 胺化率)’並不—定必須爲1 〇〇%,可依其用途或目的而 ®意地調整使用。特別佳爲50%以上。 聚醯胺酸或聚醯亞胺的反應溶液,回收聚合物成分時 ’只要使反應溶液投入於弱溶劑而使其沈澱即可。作爲沈 -30- 200944553 澱所使用的弱溶劑,可列舉甲醇、丙酮、己烷、丁基溶纖 劑、庚烷、甲基乙基酮、甲基異丁基酮、乙醇、甲苯、苯 、水等。投入於弱溶劑而使沈澱的聚合物,過濾回收後, 可於常壓或減壓下,常溫或加熱後乾燥。此外,使沈澱回 收的聚合物,再溶解於有機溶劑,重複2至10次再沈澱 回收的操作,則可減少聚合物中的雜質。作爲此時弱溶劑 ,使用例如醇類、酮類、烴等3種類以上的弱溶劑,則更 〇 進一步地提昇純化效率而較佳。 本發明所使用的聚醯胺酸及聚醯亞胺的分子量,考量 塗膜的強度、及塗膜形成時的操作性、塗膜的均勻性時, 以 GPC ( Gel Permeation Chromatography)法所測量的重 量平均分子量,使其各爲5,000至1,000,000較佳,更佳 爲 1 0,000 至 1 50,000。 &lt;液晶配向劑&gt; © 本發明的液晶配向劑,係用於製作液晶配向膜的塗佈 液,其主成分,係由形成樹脂被膜用的樹脂成分、與溶解 此樹脂成分的有機溶劑所成。於本發明中,前述的樹脂成 分,係含有上述本發明所使用的聚合物之樹脂成分。此時 ,樹脂成分的含量爲1質量%至20質量%,較佳爲2質量 %至1 0質量%。 本發明中,前述的樹脂成分,可皆爲本發明所使用的 聚合物,亦可倂用本發明的聚合物與此以外的其他聚合物 。此時,樹脂成分中之本發明的聚合物以外的其他聚合物 -31 - 200944553 的含量爲0.5質量%至15質量%,較佳爲1質量%至10質 量%。 該相關的其他聚合物,可列舉例如使特定酸二酐以外 的其他酸二酐與特定二胺化合物以外的其他二胺化合物進 行反應而得到的聚醯胺酸或聚醯亞胺等。 溶解樹脂成分的有機溶劑並沒有特別的限制。具體子 例可列舉Ν,Ν’-二甲基甲醯胺、N,N’-二甲基乙醯胺、N-甲 基-2-吡咯烷酮、N-甲基己內醯胺、2-吡咯烷酮、N-乙基 ❹ 吡咯烷酮、N-乙烯基吡咯烷酮、二甲基亞碾、四甲基尿素 、吡啶、二甲基碾、六甲基亞楓、r-丁內酯、1,3-二甲 基-咪唑烷酮、雙戊烯、乙基戊基酮、甲基壬基酮、甲基 乙基酮、甲基異戊基酮、甲基異丙基酮、環己酮、乙烯碳 酸酯、丙烯碳酸酯、二-甘醇二甲醚、4-羥基-4-甲基-2-戊 酮等。此等的溶劑可混合2種類以上使用。 使聚醯亞胺溶解於有機溶劑時,爲了促進聚醯亞胺的 溶解之目的,可加熱。因爲加熱的溫度太高則聚醢亞胺的 © 分子量會有降低的情況,溫度30由l〇〇°C較佳。特定聚 醯亞胺的溶液的濃度並沒有特別的限制,但因爲易與特定 胺化合物均勻地混合,故溶液中的特定聚醯亞胺濃度爲1 ' 至20質量%較佳,更佳爲3至1 5質量%,特別佳爲3至 1 0質量%。 本發明的液晶配向劑’亦可含有上述以外的成分。作 爲其例,亦含有將液晶配向劑製成塗佈液時提高膜厚均勻 性或表面平滑性之溶劑或化合物、提高液晶配向膜與基板 -32- 200944553 的密著性之化合物等。 作爲提高膜厚的均勻性或表面平滑性之溶劑(弱溶劑) 的具體例子,可列舉如下述者。 可列舉例如異丙醇、甲氧基甲基戊醇、甲基溶纖劑、 乙基溶纖劑'丁基溶纖劑、甲基溶纖劑乙酸酯、乙基溶纖 劑乙酸酯、丁基卡必醇、乙基卡必醇、乙基卡必醇乙酸酯 、乙二醇'乙二醇單乙酸酯、乙二醇單異丙基醚、乙二醇 Ο 單丁基醚、丙二醇、丙二醇單乙酸酯、丙二醇單甲基醚、 丙二醇-tert-丁基醚、二丙二醇單甲基醚、二乙二醇、二 乙二醇單乙酸酯、二乙二醇二甲基醚、二丙二醇單乙酸酯 單甲基醚、二丙二醇單甲基醚、二丙二醇單乙基醚、二丙 二醇單乙酸酯單乙基醚、二丙二醇單丙基醚、二丙二醇單 乙酸酯單丙基醚、3 -甲基-3 -甲氧基丁基乙酸酯、三丙二 醇甲基醚、3-甲基_3_甲氧基丁醇、二異丙基醚、乙基異 丁基醚、二異丁烯、戊基乙酸酯、丁基丁酸酯、丁基醚、 &amp; 二異丁基酮、甲基環己烯、丙基醚、二己基醚、η-己烷、 η-戊烷、η-辛烷、二乙基醚、乳酸甲酯 '乳酸乙酯、乙酸 甲酯、乙酸乙酯、乙酸 η-丁酯、乙酸丙二醇單乙基醚、 丙酮酸甲酯、丙酮酸乙酯、3 -甲氧基丙酸甲酯、3-乙氧基 丙酸甲基乙酯、3-甲氧基丙酸乙酯、3-乙氧基丙酸、3-甲 氧基丙酸、3-甲氧基丙酸丙酯、3_甲氧基丙酸丁酯、^甲 氧基-2-丙醇、1-乙氧基-2-丙醇、1-丁氧基-2-丙醇、1-苯 氧基-2-丙醇、丙二醇單乙酸酯、丙二醇二乙酸酯、丙二 醇-1-單甲基醚-2-乙酸酯、1-己醇、丙二醇-1-單乙基醚-2- -33- 200944553 乙酸酯、二丙二醇、2-(2 -乙氧基丙氧基)丙醇、乳酸甲 酯、乳酸乙酯、乳酸η-丙基酯、乳酸n_丁基酯、乳酸異 戊基酯等之具有低表面張力的溶劑等。 此等之中,以丁基溶纖劑、丙二醇單甲基醚或乳酸乙 酯較佳。 此等的弱溶劑可使用1種類,亦可混合複數種後使用 。使用如上述的溶劑時,液晶配向劑所含有的溶劑整體的 5至8 0質量%較佳,更佳爲2 0至6 0質量%。 ▲ 作爲提高膜厚的均勻性或表面平滑性之化合物,可列 舉氟系界面活性劑、聚矽氧烷系界面活性劑、非離子系界 面活性劑等。 更具體而言,可列舉例如 EF-TOP EF301、EF303、 EF3 52 ( Tohkem product 公司製)、MEGAFAC F171、 F173、R-30 (大日本油墨公司製)、Fluorade FC43 0、 FC431(住友 3M 公司製)、Asahiguard AG710、Surflon S-3 82、SC 101、SC102、SC 103、SC104、SC105、SC 1 06 ❹ (旭硝子公司製)等。此等的界面活性劑的使用比例,係 相對於液晶配向劑所含有的樹脂成分的100質量份’較佳 爲0.01至2質量份,更佳爲0.01至1質量份。 作爲提高液晶配向膜與基板的密著性的化合物的具體 例子,可列舉如下述之含有官能性矽烷的化合物或含有環 氧基的化合物者。 可列舉例如3-胺基丙基三甲氧基矽烷、3-胺基丙基三 乙氧基矽烷、2-胺基丙基三甲氧基矽烷、2-胺基丙基三乙 -34- 200944553 氧基矽烷、N- ( 2-胺基乙基)-3-胺基丙基三甲氧基矽烷 、N- (2-胺基乙基)-3-胺基丙基甲基甲氧基矽烷、3-脲基 丙基三甲氧基矽烷、3-脲基丙基三乙氧基矽烷、N-乙氧基 羰基-3-胺基丙基三甲氧基矽烷、N-乙氧基羰基-3-胺基丙 基三乙氧基矽烷、N-三乙氧基甲矽烷基丙基三乙撐三胺、 - N-三甲氧基甲矽烷基丙基三乙撐三胺、1〇_三甲氧基甲矽 烷基-1,4,7-三氮雜癸烷、10-三乙氧基甲矽烷基-1,4,7-三 φ 氮雜癸烷、9-三甲氧基甲矽烷基-3,6-二氮雜壬基乙酸酯、 9-三乙氧基甲矽烷基-3,6-二氮雜壬基乙酸酯、N-苄基- 3-胺基丙基三甲氧基矽烷、N-苄基-3-胺基丙基三乙氧基矽 烷、N-苯基-3-胺基丙基三甲氧基矽烷、N-苯基-3-胺基丙 基三乙氧基矽烷、N-雙(氧化乙烯)-3-胺基丙基三甲氧 基矽烷、N-雙(氧化乙烯)-3-胺基丙基三乙氧基矽烷、 乙二醇二縮水甘油醚、聚乙二醇二縮水甘油醚、丙二醇二 縮水甘油醚、三丙二醇二縮水甘油醚、聚丙二醇二縮水甘 © 油醚、新戊二醇二縮水甘油醚、1,6-己二醇二縮水甘油醚 、甘油二縮水甘油醚、2,2-二溴新戊二醇二縮水甘油醚、 1,3,5,6-四縮水甘油基-2,4-己二醇、:^,:^,:^’,]^’,-四縮水甘 油基-m-苯二甲胺、1,3-雙(N,N-二縮水甘油基胺基甲基 • )環己烷、N,N,N’,N’,-四縮水甘油基-4、4’-二胺基二苯 基甲烷等。 使用用於提昇與此等基板的密著性之化合物時,其使 用量係相對於液晶配向劑所含有的樹脂成分的1 00質量份 ,爲0.1至30質量份較佳,更佳爲1至20質量份。低於 -35- 200944553 0.1質量份則無法期待密著性向上的效果,多於30質量份 則會有液晶的配向性變差的情況。 本發明的液晶配向劑中,除了上述之外,若在無損及 本發明的效果的範圍,可添加目的在於使液晶配向膜的介 電常數或導電性等的電氣特性變化之介電體或導電物質, 且亦可添加目的在於提高製成液晶配向膜時的膜的硬度或 緻密度之交聯性化合物。 本發明的液晶配向劑中之固形分的濃度,可依目的之 0 液晶配向膜的膜厚而適當變更,但由使其形成無缺陷的塗 膜,且可得到作爲液晶配向膜之適切的膜厚之理由而言, 爲1至20質量%較佳,更佳爲2至1 0質量%。 &lt;液晶配向膜·液晶顯示元件&gt; 本發明的液晶配向劑,係可於基板上塗佈、燒成後, 硏磨處理或以光照射等進行配向處理,或垂直配向用途等 之無配向處理後,作爲液晶配向膜使用。此時,作爲所使 0 用的基板若爲透明性高的基板即可,並無特別的限制,可 使用玻璃基板、丙烯酸基板或聚碳酸酯基板等之塑膠基板 等。此外,使用形成有液晶驅動用的ITO電極等之基板, 由製程的簡單化的觀點而言較佳。此外,反射型的液晶顯 示元件,若僅單側的基板,亦可使用矽晶圓等之不透明物 ,此時的電極亦可使用鋁等之反射光的材料。 液晶配向劑的塗佈液方法並沒有特別的限制,但在工 業上,以網版印刷、膠版印刷、柔性版印刷、噴墨等進行 -36- 200944553 之方法爲一般作法。作爲其他塗佈液方法,有浸漬、輥塗 佈、刮刀式塗佈(slit coater )、旋轉塗佈等,可依目的 使用此等。 將液晶配向劑塗佈於基板上後的燒成,可藉由加熱板 等之加熱手段以50至300°C,較佳爲80至250°C使溶劑 蒸發,形成塗膜。燒成後的塗膜的厚度,因爲太厚則由液 晶顯示元件的消耗電力方面而言爲不利,太薄則會有液晶 Φ 顯示元件的信賴性降低的情況,較佳爲5至3 0 0 n m,更佳 爲10至lOOnm。使液晶進行水平配向或傾斜配向時,使 燒成後的塗膜以硏磨或偏光紫外線照射等進行處理。 本發明的液晶顯示元件,藉由上述的手法由本發明的 液晶配向劑得到附有液晶配向膜的基板後,以習知的方法 製作液晶胞’製成液晶顯示元件。 若列舉液晶胞製作的一例,可列舉準備1對形成有液 晶配向膜的基板’於單側的基板的液晶配向膜上散佈間隔 ® 物’使液晶配向膜面成爲內側的方式貼合另一側的基板, 減壓注入液晶後封閉之方法,或,於經散佈間隔物的液晶 配向膜面_h滴下液晶後貼合基板後進行封閉之方法等。此 時的間隔物的厚度’較佳爲1至3〇 μηι,更佳爲2至10 μιη 〇 $1] ± $ ί乍 '法’使用本發明的液晶配向劑所製作的液晶 顯示元件’係信賴性優異者,可適用於大畫面且高精細的 液晶電視等。 -37- 200944553 【實施方式】 [實施例] 以下列舉實施例,更詳細地說明本發明,但並不限定 於此等實施例。 以下,列示實施例所使用的化合物的簡寫與結構# ° (四羧酸二酐)Methyl ester, methyl 3-ethoxypropionate ethyl, ethyl 3-methoxypropionate, 3-ethoxypropionic acid, 3-methoxypropionic acid, propyl 3-methoxypropionate , 3-methoxypropionic acid butyl, diglyme, 4-hydroxy-4-methyl-2-pentanone, and the like. These can be used alone or in combination. Further, even a solvent which does not dissolve the polyamic acid may be used in the above solvent as long as it does not precipitate the produced polyamic acid. Further, since the water in the organic solvent hinders the polymerization reaction, and in order to hydrolyze the produced polylysine, it is preferred that the organic solvent be dehydrated as much as possible. As a method of reacting a tetracarboxylic dianhydride and a diamine compound in an organic solvent, a method of dispersing or dissolving a diamine compound in an organic solvent, and directly adding a tetracarboxylic dianhydride, or a method of dispersing or dissolving in an organic solvent; and conversely adding a diamine compound to a solution in which a tetracarboxylic dianhydride is dispersed or dissolved in an organic solvent; and a tetracarboxylic acid dianhydride and a diamine compound are alternately added. The method, etc., can be any of these methods. • When the tetracarboxylic dianhydride or the diamine compound is a compound of a plurality of kinds, it can be reacted in a state of being mixed beforehand, and it can be reacted in an individual order and reacted individually. A high molecular weight body in which a low molecular weight body is subjected to a mixed reaction may also be used. The temperature at which the above polylysine is synthesized may be any temperature selected from -20 ° C to 150 ° C, but preferably in the range of -5 ° C to 100 ° C. Further, the reaction can be carried out at any concentration, but since the concentration is too low, it is difficult to obtain a polymer having a high molecular weight, and if the concentration is too high, the viscosity of the reaction liquid becomes too high and uniform stirring becomes difficult 'tetracarboxylic dianhydride and diamine. The total concentration in the reaction solution of the component is preferably from 1 to 50% by mass, more preferably from 5 to 30% by mass. The anti-β should be carried out at a high concentration in the initial stage, and then an organic solvent can be added. In the synthesis reaction of polyamine, the ratio of the number of moles of the diamine component to the number of moles of the tetracarboxylic dianhydride component is preferably from 0.8 to 1.2. The usual polycondensation reaction is similar to the fact that the closer the molar ratio is to 1.0, the greater the molecular weight of the polylysine formed. The polyimine used in the present invention is a polyimine obtained by subjecting the above polyamic acid to dehydration ring closure, and is suitable as a polymer for obtaining a liquid crystal alignment film. In the polyimine used in the present invention, the dehydration ring closure ratio of the valeric acid group is -29-200944553 (the imidization ratio), and does not necessarily have to be 100%, and can be arbitrarily adjusted depending on the purpose or purpose thereof. use. Examples of the method for imidizing polyphosphonium hydrazide include a hydrazine imidization in which a solution of polylysine is directly heated, and a catalyst oxime imidization in which a catalyst is added to a solution of polyamic acid. The temperature at which the polyaminic acid is thermally imidized in the solution is from 100 ° C to 400 ° C, preferably from 120 ° C to 25 (rc, while removing water formed by the hydrazine imidization reaction to It is preferred to carry out the outside of the system. The catalyst of φ poly-proline is imidized, and a basic catalyst and an acid anhydride can be added to the solution of poly-proline, by -2 0 to 250 ° C. Preferably, the stirring is carried out at a temperature of from 180 ° C. The amount of the basic catalyst is 〇. 5 to 30 moles of the valeric acid group is preferably 2 to 20 moles, and the amount of the acid anhydride is guanamine. The acid group is 1 to 50 moles, preferably 3 to 30 moles. As the basic catalyst, pyridine, triethylamine, trimethylamine, tributylamine, trioctylamine, etc. may be mentioned. Further, pyridine is preferred because it has a moderate basicity required for the reaction to proceed. Examples of the acid anhydride include acetic anhydride, trimellitic anhydride, and pyromellitic anhydride, among which acetic anhydride is used because of the reaction. Purification after completion is preferred and preferred. The imidization rate of the imidization of the catalyst oxime can be controlled by adjusting the amount of the catalyst, the reaction temperature, and the reaction time. In the amine, the dehydration ring closure ratio of the proline group (the imidization ratio) must not be 1%, and can be adjusted according to its use or purpose. Especially preferably 50% or more. When the reaction solution of valine or polyimine is recovered, when the polymer component is recovered, the reaction solution may be precipitated by putting it into a weak solvent. The weak solvent used in the precipitation is exemplified by methanol. Acetone, hexane, butyl cellosolve, heptane, methyl ethyl ketone, methyl isobutyl ketone, ethanol, toluene, benzene, water, etc. The polymer precipitated in a weak solvent can be filtered and recovered. Drying at normal temperature or after heating under normal pressure or reduced pressure. Further, by re-dissolving the polymer recovered by precipitation in an organic solvent and repeating the reprecipitation recovery 2 to 10 times, impurities in the polymer can be reduced. In this case, it is preferred to use a weak solvent of three or more kinds, such as an alcohol, a ketone or a hydrocarbon, to further improve the purification efficiency. The molecular weight of the polyglycolic acid and the polyimine used in the present invention. Consider the strength of the film and apply In the case of the workability at the time of film formation and the uniformity of the coating film, the weight average molecular weight measured by the GPC (Gel Permeation Chromatography) method is preferably 5,000 to 1,000,000, more preferably 10,000 to 150,000. &lt;Liquid crystal alignment agent&gt; The liquid crystal alignment agent of the present invention is a coating liquid for producing a liquid crystal alignment film, and the main component thereof is a resin component for forming a resin film and an organic solvent for dissolving the resin component. In the present invention, the resin component described above contains the resin component of the polymer used in the present invention. In this case, the content of the resin component is from 1% by mass to 20% by mass, preferably from 2% by mass to 1%. 0% by mass. In the present invention, the above-mentioned resin components may be all of the polymers used in the present invention, and the polymers of the present invention and other polymers may be used. In this case, the content of the other polymer -31 - 200944553 other than the polymer of the present invention in the resin component is from 0.5% by mass to 15% by mass, preferably from 1% by mass to 10% by mass. The other polymer to be used may, for example, be a polylysine or a polyimine obtained by reacting another acid dianhydride other than the specific acid dianhydride with another diamine compound other than the specific diamine compound. The organic solvent in which the resin component is dissolved is not particularly limited. Specific examples include hydrazine, Ν'-dimethylformamide, N,N'-dimethylacetamide, N-methyl-2-pyrrolidone, N-methylcaprolactam, 2-pyrrolidone , N-ethyl 吡 pyrrolidone, N-vinyl pyrrolidone, dimethyl sub-milling, tetramethyl urea, pyridine, dimethyl milling, hexamethyl sulfoxide, r-butyrolactone, 1,3-dimethyl -imidazolidinone, dipentene, ethyl amyl ketone, methyl decyl ketone, methyl ethyl ketone, methyl isoamyl ketone, methyl isopropyl ketone, cyclohexanone, ethylene carbonate, Propylene carbonate, diglyme, 4-hydroxy-4-methyl-2-pentanone, and the like. These solvents can be used in combination of two or more types. When the polyimine is dissolved in an organic solvent, it can be heated for the purpose of promoting the dissolution of the polyimide. Since the heating temperature is too high, the molecular weight of the polyimide may be lowered, and the temperature 30 is preferably from 10 °C. The concentration of the solution of the specific polyimine is not particularly limited, but the concentration of the specific polyimine in the solution is preferably from 1 ' to 20% by mass, more preferably 3, because it is easily mixed uniformly with the specific amine compound. It is up to 15% by mass, particularly preferably from 3 to 10% by mass. The liquid crystal alignment agent ' of the present invention' may contain components other than the above. As an example, a solvent or a compound which improves film thickness uniformity or surface smoothness when a liquid crystal alignment agent is used as a coating liquid, and a compound which improves adhesion between a liquid crystal alignment film and a substrate -32-200944553 are also contained. Specific examples of the solvent (weak solvent) for improving the uniformity of the film thickness or the surface smoothness include the following. For example, isopropyl alcohol, methoxymethylpentanol, methyl cellosolve, ethyl cellosolve 'butyl cellosolve, methyl cellosolve acetate, ethyl cellosolve acetate, and butyl Kikabi alcohol, ethyl carbitol, ethyl carbitol acetate, ethylene glycol 'ethylene glycol monoacetate, ethylene glycol monoisopropyl ether, ethylene glycol oxime monobutyl ether, Propylene glycol, propylene glycol monoacetate, propylene glycol monomethyl ether, propylene glycol-tert-butyl ether, dipropylene glycol monomethyl ether, diethylene glycol, diethylene glycol monoacetate, diethylene glycol dimethyl Ether, dipropylene glycol monoacetate monomethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol monoacetate monoethyl ether, dipropylene glycol monopropyl ether, dipropylene glycol monoacetic acid Ester monopropyl ether, 3-methyl-3-methoxybutyl acetate, tripropylene glycol methyl ether, 3-methyl-3-methoxybutanol, diisopropyl ether, ethyl Butyl ether, diisobutylene, pentyl acetate, butyl butyrate, butyl ether, &amp; diisobutyl ketone, methyl cyclohexene, propyl ether, dihexyl ether, η-hexane, Η-pentane, η-octane Diethyl ether, methyl lactate 'ethyl lactate, methyl acetate, ethyl acetate, η-butyl acetate, propylene glycol monoethyl ether, methyl pyruvate, ethyl pyruvate, 3-methoxy propyl Methyl ester, methyl 3-ethoxypropionate, ethyl 3-methoxypropionate, 3-ethoxypropionic acid, 3-methoxypropionic acid, 3-methoxypropionic acid Ester, butyl 3-methoxypropionate, methoxy-2-propanol, 1-ethoxy-2-propanol, 1-butoxy-2-propanol, 1-phenoxy- 2-propanol, propylene glycol monoacetate, propylene glycol diacetate, propylene glycol-1-monomethyl ether-2-acetate, 1-hexanol, propylene glycol-1-monoethyl ether-2-33 - 200944553 Acetate, dipropylene glycol, 2-(2-ethoxypropoxy)propanol, methyl lactate, ethyl lactate, η-propyl lactate, n-butyl lactate, isoamyl lactate A solvent or the like having a low surface tension such as an ester. Among these, butyl cellosolve, propylene glycol monomethyl ether or ethyl lactate is preferred. These weak solvents may be used in one type or in combination of plural kinds. When the solvent is used as described above, the solvent contained in the liquid crystal alignment agent is preferably from 5 to 80% by mass, more preferably from 20 to 60% by mass. ▲ As a compound for improving the uniformity of the film thickness or the surface smoothness, a fluorine-based surfactant, a polyoxyalkylene-based surfactant, a nonionic surfactant, or the like can be given. More specifically, for example, EF-TOP EF301, EF303, EF3 52 (manufactured by Tohkem Product Co., Ltd.), MEGAFAC F171, F173, R-30 (manufactured by Dainippon Ink Co., Ltd.), Fluorade FC43 0, FC431 (manufactured by Sumitomo 3M Co., Ltd.) ), Asahiguard AG710, Surflon S-3 82, SC 101, SC102, SC 103, SC104, SC105, SC 1 06 ❹ (made by Asahi Glass Co., Ltd.). The use ratio of the surfactant is preferably 0.01 to 2 parts by mass, more preferably 0.01 to 1 part by mass, per 100 parts by mass of the resin component contained in the liquid crystal alignment agent. Specific examples of the compound which improves the adhesion between the liquid crystal alignment film and the substrate include those having a functional decane or a compound containing an epoxy group. For example, 3-aminopropyltrimethoxydecane, 3-aminopropyltriethoxydecane, 2-aminopropyltrimethoxydecane, 2-aminopropyltriethyl-34-200944553 oxygen Baseline, N-(2-aminoethyl)-3-aminopropyltrimethoxydecane, N-(2-aminoethyl)-3-aminopropylmethylmethoxydecane, 3 -ureidopropyltrimethoxydecane, 3-ureidopropyltriethoxydecane, N-ethoxycarbonyl-3-aminopropyltrimethoxydecane, N-ethoxycarbonyl-3-amine Propyltriethoxydecane, N-triethoxycarbamidopropyltriethylenetriamine, -N-trimethoxycarbamidopropyltriethylenetriamine, 1〇-trimethoxymethyl矽alkyl-1,4,7-triazadecane, 10-triethoxycarbamimidyl-1,4,7-tri-xazadecane, 9-trimethoxyformamidin-3,6 - diazaindolyl acetate, 9-triethoxycarbamido-3,6-diazaindolyl acetate, N-benzyl-3-aminopropyltrimethoxydecane, N -benzyl-3-aminopropyltriethoxydecane, N-phenyl-3-aminopropyltrimethoxydecane, N-phenyl-3-aminopropyltriethoxydecane, N - double (oxidation Alkyl-3-aminopropyltrimethoxydecane, N-bis(oxyethylene)-3-aminopropyltriethoxydecane, ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether , propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, polypropylene glycol diglycidyl ether, neopentyl glycol diglycidyl ether, 1,6-hexanediol diglycidyl ether, glycerol diglycidyl ether, 2,2-dibromoneopentyl glycol diglycidyl ether, 1,3,5,6-tetraglycidyl-2,4-hexanediol, :^,:^,:^',]^', -tetraglycidyl-m-xylylenediamine, 1,3-bis(N,N-diglycidylaminomethyl)cyclohexane, N,N,N',N',-tetrahydration Glyceryl-4,4'-diaminodiphenylmethane, and the like. When the compound for improving the adhesion to the substrate is used, the amount thereof is preferably from 0.1 to 30 parts by mass, more preferably from 1 to 10 parts by mass, per 100 parts by mass of the resin component contained in the liquid crystal alignment agent. 20 parts by mass. When the amount is less than -35 - 200944553, 0.1 parts by mass cannot be expected to have an effect of adhesion, and when it is more than 30 parts by mass, the alignment of the liquid crystal may be deteriorated. In the liquid crystal alignment agent of the present invention, in addition to the above, a dielectric or a conductive material which changes electrical characteristics such as a dielectric constant or conductivity of the liquid crystal alignment film may be added without departing from the effects of the present invention. A substance or a crosslinkable compound which is intended to increase the hardness or density of the film when the liquid crystal alignment film is formed may be added. The concentration of the solid content in the liquid crystal alignment agent of the present invention can be appropriately changed depending on the film thickness of the target liquid crystal alignment film, but a coating film having no defects can be formed, and a suitable film as a liquid crystal alignment film can be obtained. For the reason of the thickness, it is preferably from 1 to 20% by mass, more preferably from 2 to 10% by mass. &lt;Liquid Crystal Alignment Film/Liquid Crystal Display Element&gt; The liquid crystal alignment agent of the present invention can be subjected to honing treatment, alignment treatment by light irradiation or the like, or alignment in the vertical alignment, etc. after application and baking on a substrate. After the treatment, it is used as a liquid crystal alignment film. In this case, the substrate to be used for the purpose of the substrate is not particularly limited, and a plastic substrate such as a glass substrate, an acrylic substrate or a polycarbonate substrate can be used. Further, it is preferable to use a substrate on which an ITO electrode or the like for liquid crystal driving is formed, from the viewpoint of simplification of the process. Further, in the reflective liquid crystal display device, an opaque material such as a germanium wafer may be used as the substrate on only one side, and a material such as aluminum or the like may be used as the electrode. The coating liquid method of the liquid crystal alignment agent is not particularly limited, but industrially, the method of -35-200944553 is carried out by screen printing, offset printing, flexographic printing, ink jetting, etc., as a general method. As other coating liquid methods, there are immersion, roll coating, slit coater, spin coating, etc., and these can be used depending on the purpose. After the liquid crystal alignment agent is applied onto the substrate, the solvent can be evaporated by a heating means such as a hot plate at 50 to 300 ° C, preferably 80 to 250 ° C to form a coating film. The thickness of the coating film after firing is too low in terms of power consumption of the liquid crystal display element, and if it is too thin, the reliability of the liquid crystal Φ display element may be lowered, preferably 5 to 300. Nm is more preferably 10 to 100 nm. When the liquid crystal is horizontally aligned or obliquely aligned, the coating film after firing is treated by honing or polarized ultraviolet irradiation or the like. In the liquid crystal display device of the present invention, a liquid crystal display cell is produced by a known method from the liquid crystal alignment agent of the present invention, and a liquid crystal cell is produced by a conventional method. An example of the production of the liquid crystal cell is as follows: one of the substrates on which the liquid crystal alignment film is formed is disposed on the liquid crystal alignment film of the substrate on one side, and the spacer is disposed on the liquid crystal alignment film, so that the liquid crystal alignment film surface is inside. The substrate is sealed by a method of injecting liquid crystals under reduced pressure, or a method of sealing the substrate after dropping the liquid crystal through the liquid crystal alignment film surface of the spacer, and then sealing the substrate. The thickness of the spacer at this time is preferably 1 to 3 〇μηι, more preferably 2 to 10 μηη 〇 $1] ± $ 乍 乍 ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' Excellent for those who are large screens and high-definition LCD TVs. [Embodiment] [Embodiment] Hereinafter, the present invention will be described in more detail by way of examples, but not limited thereto. Hereinafter, the abbreviations and structures of the compounds used in the examples are shown in #° (tetracarboxylic dianhydride)

BODA:雙環[3,3,〇]辛烷-2,4,6,8-四羧酸二酐 CBDA: 1,2,3,4-環丁烷四羧酸二酐 TDA: 3,4-二羧基-1,2,3,4-四氫-1-萘琥珀酸二酐 PMDA:均苯四甲酸二酐 [化 24]BODA: bicyclo[3,3,〇]octane-2,4,6,8-tetracarboxylic dianhydride CBDA: 1,2,3,4-cyclobutanetetracarboxylic dianhydride TDA: 3,4- Dicarboxy-1,2,3,4-tetrahydro-1-naphthalene succinic dianhydride PMDA: pyromellitic dianhydride [Chemical 24]

(二胺化合物) p-PDA : p-苯撐二胺 m-PDA: m -苯擦二胺 PCH7DAB: 1,3-二胺基-4-[4-(4 -庚基環己基)苯氧 苯 DBA: 3,5 -二胺基苯甲酸 -38- 200944553 2,4-DAA: 2,4-二胺基-N,N-二烯丙基苯胺 DADPA: 4,4’-二胺基二苯基胺 [化 25](Diamine compound) p-PDA : p-phenylenediamine m-PDA: m - benzene rub diamine PCH7DAB: 1,3-diamino-4-[4-(4-heptylcyclohexyl)phenoxy Benzene DBA: 3,5-diaminobenzoic acid-38- 200944553 2,4-DAA: 2,4-diamino-N,N-diallylaniline DADPA: 4,4'-diaminodi Phenylamine

H2N h2H2N h2

p-PDAP-PDA

h2H2

(有機溶劑) NMP : N-甲基-2-吡咯烷酮 BCS : 丁基溶纖劑 GBL : γ-丁內酯 ❹ &lt;分子量測量&gt; 合成例中聚醯亞胺的分子量,係使用昭和電工公司製 常溫凝膠滲透色譜法(GPC )裝置(GPC-101 ) 、Shodex 公司製管柱(KD-8 03、KD-8 05 )如下述進行測量。(Organic solvent) NMP : N-methyl-2-pyrrolidone BCS : butyl cellosolve GBL : γ-butyrolactone ❹ &lt;Molecular weight measurement&gt; The molecular weight of the polyimine in the synthesis example is the normal temperature of the Showa Denko company. A gel permeation chromatography (GPC) apparatus (GPC-101) and a pipe column (KD-8 03, KD-8 05) manufactured by Shodex Co., Ltd. were measured as follows.

管柱溫度:5 0 °C 溶離液:Ν ,Ν ’ -二甲基甲醯胺(作爲添加劑,溴化鋰· 水合物(LiBr*H2〇)爲30mmol/L、碟酸.無水結晶(〇 -磷 酸)爲 30mmol/L、四氫呋喃(THF)爲 10ml/L) -39- 200944553 流速:l.Oml/分鐘 檢量線製成用標準試樣··東曹公司製 TSK標準聚環 氧乙烷(分子量 900,000、 150,000、 100,000、 30,000)、 及、Polymer Laboratories 公司製聚乙二醇(分子量約 12,000、4,000 ' 1,000 )。 &lt;醯亞胺化率的測量&gt; 合成例中聚醯亞胺的醯亞胺化率如下述作法測量。將 聚醯亞胺粉末20mg放入NMR試樣管(草野科學公司製 NMR sampling tube standard φ 5)中,添加重氫化二甲基 亞楓(DMSO-d6、0.05%TMS (四甲基矽烷)混合品) 0.53ml,施力口超音波使其完全地溶解。將此溶液用日本電 子 DATUM公司製 NMR測量器(JNW-ECA500 )測量 5 00MHz的質子NMR。醯亞胺化率,係以來自醯亞胺化前 後未變化的結構的質子作爲基準質子而決定,使用此質子 的最大積分値(integrated value of a peak)、與出現在 9.5至l〇. 〇ppm附近之來自醯胺酸的NH基的質子最大積 分値,由下式求得。 醯亞胺化率(% ) = ( 1-α · x/y ) X 1〇〇 於上述式,x爲來自醯胺酸的NH基的質子最大積分 値、y爲基準質子的最大積分値、α爲聚醯胺酸(醯亞胺 化率爲0% )時,相對於醯胺酸的ΝΗ基質子1個之基準 200944553 質子的個數比例。 &lt;合成例1&gt; 將 BOD A ( 3 · 7 5 g, 1 5 mmol ) 、DBA ( 2.3 g, 1 5mmol )、 及 PCH7DAB ( 3_8g,l〇mmol)於 NMP ( 16.5g)中混合, 以5 0°C使其反應5小時後,加入CBDA ( 1.96g,10mmol) 與NMP ( 13.0g),以40 °C使其反應12小時後得到樹脂 φ 含量爲29質量%的聚醯胺酸溶液(A )。此聚醯胺酸的數 平均分子量爲22,700、重量平均分子量爲45,100。 &lt;合成例2&gt; 將 TD A ( 3 .Og,1 Ommol ) 、D B A ( 2.3 g,1 5 mmo 1 )、及 PCH7DAB ( 3.8g,10mmol )於 NMP ( 28.8g)中混合,以 5〇°C使其反應5小時後,加入CBDA(2.9g,15mmol)與 NMP ( 19.3g),以4 0 °C使其反應1 2小時後得到聚醯胺酸 β 溶液。 於此聚醯胺酸溶液(20.0g )中加入ΝΜΡ稀釋成6質 量%後,加入作爲醯亞胺化觸媒之乙酸酐(2.4 g )、及吡 啶(l.Og) ’以40°C使其反應2小時。將此反應溶液投入 甲醇(25 0ml )中,濾別所得到的沈澱物。將此沈澱物用 甲醇洗淨,以1 00 °C減壓乾燥而得到聚醯亞胺粉末(B ) 。此聚醯亞胺的醯亞胺化率爲59%,數平均分子量爲 11,700、重量平均分子量爲24,100。 -41 - 200944553 &lt;合成例3&gt; 於合成例2所得到的聚醯胺酸溶液(20.0g )中加入 NMP稀釋成6質量%後,加入作爲醯亞胺化觸媒之乙酸酐 (2 _ 4 g )、及吡啶(1.0 g ),以5 0 °C使其反應3小時。將 此反應溶液投入甲醇(250ml )中,濾別所得到的沈澱物 。將此沈澱物用甲醇洗淨,以1 〇〇 °C減壓乾燥而得到聚醯 亞胺粉末(C)。此聚醯亞胺的醯亞胺化率爲82%,數平 均分子量爲1 3,600、重量平均分子量爲3 1,400。 &lt;合成例4&gt; 將 CBDA ( 5.0g,25mmol ) 、2,4 - D A A ( 1 · 6 g,8 · 0 m m ο 1 )、DBA ( 1.2g,8.0mmol )、及 PCH7DAB ( 4.0g,1 Ommol )於NMP ( 47.3g )中混合,以23 °C使其反應15小時而 得到聚醯胺酸溶液。 於此聚醯胺酸溶液(20.0g)中加入NMP稀釋成6質 量%後,加入作爲醯亞胺化觸媒之乙酸酐(4.3g )、及吡 啶(3.3g),以5(TC使其反應3小時。將此反應溶液投入 甲醇(260ml )中,濾別所得到的沈澱物。將此沈澱物用 甲醇洗淨,以100 °C減壓乾燥而得到聚醯亞胺粉末(D) 。此聚醯亞胺的醯亞胺化率爲96%,數平均分子量爲 19,100、重量平均分子量爲45,500。 &lt;合成例5 &gt; 將 BODA ( 24.4g,1 OOmmol ) 、DBA ( 1 3 . 8g,9 1 mmol ) 200944553 、及 PCH7DAB ( 14.8g,39mmol)於 NMP ( 141.6g)中混 合,以 8 0 °C使其反應 5 小時後,加入 CBDA ( 6.0g,31mmol)與 NMP(94.4g),以 401 使其反應 12 小 時後得到聚醯胺酸溶液。 於此聚醯胺酸溶液(50.〇g)中加入NMP稀釋成6質 量%後,加入作爲醯亞胺化觸媒之乙酸酐(5.6 g )、及吡 啶(4 · 3 g ),以8 0 °C使其反應3小時。將此反應溶液投入 〇 甲醇(6 0 0 m 1 )中,濾別所得到的沈澱物。將此沈澱物用 甲醇洗淨,以1 0 〇 °c減壓乾燥而得到聚醯亞胺粉末(E ) 。此聚醯亞胺的醯亞胺化率爲 55%,數平均分子量爲 1 9,800、重量平均分子量爲62,700。 &lt;合成例6&gt; 將 BODA ( 24.4g, 1 OOmmol ) 、DBA ( 1 1.9g,78mmol ) 、及 PCH7DAB ( 19.8g,52mmol )於 NMP ( 149.Og)中混 ® 合,以 80 °C使其反應 5 小時後,加入 CBDA ( 6.0g,31mmol)與 NMP ( 99.2g),以 40°C 使其反應 12 小 時後得到聚醯胺酸溶液。 於此聚醯胺酸溶液(8 0.0g )中加入NMP稀釋成6質 量%後,加入作爲醯亞胺化觸媒之乙酸酐(1 7.9g )、及吡 啶(13.8g),以90°C使其反應3小時。將此反應溶液投 入甲醇(1 000ml )中,濾別所得到的沈澱物。將此沈澱物 用甲醇洗淨,以100 °C減壓乾燥而得到聚醯亞胺粉末(F )。此聚醯亞胺的醯亞胺化率爲81%,數平均分子量爲 -43- 200944553 20,1 00、重量平均分子量爲68,100。 &lt;合成例7&gt; 將 BODA ( 24.4g,l OOmmol ) 、D B A ( 1 3 · 8 g,9 1 mm ο 1 ) 、及 PCH7DAB ( 14.8g,39mmol )於 NMP ( 141.6g)中混 合,以 80 V使其反應 5小時後,加入 CBDA ( 6.0g,31mmol)與 NMP(94.4g),以 40°C 使其反應 12 小 時後得到聚醯胺酸溶液。 於此聚醯胺酸溶液(50.0g )中加入NMP稀釋成6質 量%後,加入作爲醯亞胺化觸媒之乙酸酐(11.2g )、及吡 啶(8.7g ),以90°C使其反應3.5小時。將此反應溶液投 入甲醇(600ml )中,濾別所得到的沈澱物。將此沈澱物 用甲醇洗淨,以1 〇〇 °C減壓乾燥而得到聚醯亞胺粉末(G )。此聚醯亞胺的醯亞胺化率爲80%,數平均分子量爲 1 9,500、重量平均分子量爲62,200。 &lt;合成例8&gt; 將 T D A ( 1 2.0 g, 4 0 m m ο 1 ) 、DBA ( 3.0g,20mmol)、 及 p-PDA(2.2g,20mmol)於 NMP(68.8g)中混合,以 5 0 °C使其反應1 5小時而得到聚醯胺酸溶液。 於此聚醯胺酸溶液(50.Og)中加入NMP稀釋成6質 量%後,加入作爲醯亞胺化觸媒之乙酸酐(2 3 · 7 g )、及吡 啶(1 1.0 g ),以5 0 °C使其反應3小時。將此反應溶液投 入甲醇(8 2 0 m 1 )中,濾別所得到的沈澱物。將此沈澱物 200944553 用甲醇洗淨,以1 〇〇°c減壓乾燥而得到聚醯亞胺粉末(Η )。此聚醯亞胺的醯亞胺化率爲88%,數平均分子量爲 1 7,700、重量平均分子量爲65,700。 &lt;合成例9&gt; 將 TD A ( 6.0g, 2 0mm ο 1 ) 、DB A ( 1 . 5 g,1 0 mmο 1 )、及 DADPA(2.0g,10mmol)於 NMP(38.1g)中混合,以 50 φ °C使其反應1 5小時而得到聚醯胺酸溶液。 於此聚醯胺酸溶液(30.0g)中加入NMP稀釋成6質 量%後,加入作爲醯亞胺化觸媒之乙酸酐(12.9g)、及吡 啶(6.0g),以50°C使其反應3小時。將此反應溶液投入 甲醇(500ml )中,濾別所得到的沈澱物。將此沈澱物用 甲醇洗淨,以1 〇〇 °C減壓乾燥而得到聚醯亞胺粉末(1 ) 。此聚醯亞胺的醯亞胺化率爲8 8 %,數平均分子量爲 1 8,000、重量平均分子量爲72,900。 ❹ &lt;合成例1 〇 &gt; 將 CBD A ( 3.0g,1 6mmol ) 、p-PD A ( 0.9g, 8mmο 1 )、 及 PCH7DAB ( 3.0g,8mmol)於 NMP ( 39.4g)中混合,以 2 3°C使其反應20小時而得到樹脂含量爲15質量%的聚醯 胺酸溶液(J)。此聚醯胺酸的數平均分子量爲27,000、 重量平均分子量爲63,000。 〈合成例11&gt; -45- 200944553 將 PMDA ( 2.6g,1 2mmol ) 、p-PDA ( 0.7g,6mmol )、 及 PCH7DAB ( 2.3g,6mmol)於 NMP ( 32.0g)中混合’以 2 3 °C使其反應20小時而得到樹脂含量爲1 5質量%的聚醯 胺酸溶液(K)。此聚醯胺酸的數平均分子量爲28,300、 重量平均分子量爲71,200。 &lt;合成例1 2 &gt; 將 TD A ( 3 · 1 g,1 Ommol ) 、m-PD A ( 1 · 7 g,1 6mmo 1 )、 及 PCH7DAB(4.〇g,l〇mm〇l)於 NMP(28.4g)中混合, 以50°C使其反應5小時後,加入CBDA ( 3.0g,l 6mmol ) 與NMP ( 18_9g),以40°C使其反應12小時後得到聚醯 胺酸溶液。 於此聚醯胺酸溶液(20.0g )中加入NMP稀釋成6質 量%後,加入作爲醯亞胺化觸媒之乙酸酐(2.6g )、及吡 啶(1 . 1 g ),以5 (TC使其反應3小時。將此反應溶液投入 甲醇(2 5 0ml )中,濾別所得到的沈澱物。將此沈澱物用 甲醇洗淨,以〗〇〇 °C減壓乾燥而得到聚醯亞胺粉末(L ) 。此聚醯亞胺的醯亞胺化率爲 79%,數平均分子量爲 1 2,000、重量平均分子量爲27,900。 200944553 [表i] 合成 例 四羧酸二酐 (mmol) 二胺化合物 (mmol) 醯亞胺 化率 (%) 特定酸二酐 其他的酸 二酐 特定二胺 其他二胺 1 聚醯胺酸 (A) CBDA(10) BODA(15) - DBA(15) PCH7DAB(10) - 2 聚醯亞胺 粉末(B) TDA(IO) CBDA(15) - DBA(15) PCH7DAB(10) 59 3 聚醯亞胺 粉末(C) TDA(IO) CBDA(15) - DBA(15) PCH7DAB(10) 82 4 聚醯亞胺 粉末(D) CBDA(25) - DBA(8) PCH7DAB(10) 2,4-DAA(8) 96 5 聚醯亞胺 粉末⑹ CBDA(31) BODA(IOO) - DBA(91) PCH7DAB(39) 55 6 聚醯亞胺 粉末(F) CBDA(31) BODA(IOO) - DBA(78) PCH7DAB(52) 81 7 聚醯亞胺 粉末(G) CBDA(31) BODA(IOO) - DBA(91) PCH7DAB(39) 80 8 聚醯亞胺 粉末(H) TDA(40) - DBA(20) p-PDA(20) 88 9 聚醯亞胺 粉末(I) TDA(20) - DBA(10) DADPA(IO) 88 10 聚醯胺 酸(J) CBDA(16) - - p-PDA ⑻ PCH7DAB(8) - 11 聚醯胺 酸(K) - PMDA(12) - p-PDA ⑹ PCH7DAB(6) - 12 聚醯亞胺 粉末(L) TDA(10) CBDA(16) - - m-PDA(16) PCH7DAB(10) 79 -47- 200944553 表中’ 「四羧酸二酐」的欄位及「二胺化合物」的攔 位中之「-」,各自表示不使用該酸二酐、特定二胺。 &lt;實施例1&gt; 於合成例1所得到的聚醯胺酸溶液(A) ( lO.Og )中 . 加入 NMP(12.5g)、及 BCS(25.5g),藉由以 251:進 行2小時攪拌,得到液晶配向劑[i ]。於此液晶配向劑未 見到混濁或析出等異常,確認樹脂成分均勻地溶解。 ❹ [液晶胞的製作] 將上述所得到的液晶配向劑[1 ]旋塗佈於附有ITO電 極的玻璃基板,於8 0 °c的加熱板上使其乾燥5分鐘後, 以220 °C的熱風循環式烘箱進行15分鐘燒成,製作膜厚 1 OOnm的液晶配向膜。準備2片附有此液晶配向膜的基板 ,於其1片的液晶配向膜面上散佈6μιη的間隔物後,於 其上印刷密封劑,貼合後、使密封劑硬化後製作空液晶胞 © 。於此空液晶胞中藉由減壓注入法,注入液晶ML C-66 0 8 (MERCK . JAPAN公司製),封閉注入口,而得到向列型 液晶胞。 以偏光顯微鏡觀察此液晶胞的結果,液晶爲均勻地垂 直配向,未見到配向缺陷等。 [表面自由能量極性項的評估] 本發明中,液晶配向膜表面易吸附吸附水或雜質’於 -48 - 200944553 ODF步驟中液晶被滴下時,作爲抑制附著於液晶配向膜表 面之吸附水或雜質被集中之評估方法,注目於液晶配向膜 的表面自由能量極性項之値。此値愈大者,其效果愈高。 將上述所得到的液晶配向劑[1]旋塗佈於附有ITO電 極的玻璃基板,於80°C的加熱板上使其乾燥5分鐘後, 以220°C的熱風循環式烘箱進行15分鐘燒成,製作膜厚 1 OOnm的液晶配向膜。使用附有此液晶配向膜的基板,測 〇 量純水與二碘甲烷的接觸角。使用此等接觸角,依照文獻 [JOURNAL OF APPLIED POLYMER SCIENCE VOL.13,PP.1741-1747 ( 1969)]中所記載之 D.K.OWΕΝS 等人的方法,計算出表面自由能量(亦稱爲表面張力)極 性項。 (l+COS0)xyL = 2(YSdxYLd)l/2 + 2(YSpxyLp)l/2 式[i] •其中,yL=yLd+yLp ' YS=ySd+YSp θ:塗膜上的液體的接觸角 γί:液體的表面自由能量 YLd:液體的表面自由能量分散項 yLP :液體的表面自由能量極性項 ys :塗膜的表面自由能量 ysd :塗膜的表面自由能量分散項 ySp :塗膜的表面自由能量極性項 -49- 200944553 而且,將於20°C之水的表面張力(7L = 72.8、 r Ld = 21.8 ' r Lp = 5 1 .0 ) ( mPa s )與二碘甲烷的表面張 力(r L = 50.8、γ Ld = 49.5 &gt; r Lp=l .3 ) (mPa-s)代入式 [i]中,則純水時得到下述式[ii],爲二碘甲烷時得到式 [iii]。其中,01、02各自爲水的接觸角與二碘甲烷( CH2I2 )的接觸角。 (l+COS0 1)x72.8 = 2(YSdx2 1.8)l/2 + 2(ySpx5 1.O)l/2 式[ii] (l+COS02)x5O.8 = 2(YSdx49.5)l/2 + 2(ySpx 1.3)1/2 式[iii] 故,式[ii]、式[iii]中代入純水與二碘甲烷的接觸角 ,由此連立方程式求得rsP。 再者,接觸角係使用接觸角測量裝置CA — W (協和 界面化學公司製),將水3//1、二碘甲烷1#1滴下於塗 膜上,藉由測量5秒後的接觸角而求得。結果係列示於後 述的表2。 &lt;實施例2&gt; 於合成例2所得到的聚醯亞胺粉末(B ) (5.0g)中 加入NMP ( 24.3g ),藉由以70°C進行40小時攪拌而使 其溶解。於此溶液中加入NMP (12.3g)、及BCS(41.5g ),藉由以25 °C進行2小時攪拌,得到液晶配向劑[2]。 於此液晶配向劑未見到混濁或析出等異常,確認樹脂成分 均勻地溶解。 -50- 200944553 使用所得到的液晶配向劑[2],與實施例1同樣地製 作液晶胞。結果,液晶爲均勻地垂直配向,未見到配向缺 陷等,且,與實施例1同樣地評估表面自由能量極性項。 結果係列示於後述的表2。 、 &lt;實施例3&gt; 於合成例3所得到的聚醯亞胺粉末(C ) ( 5 · 1 g )中 Φ 加入NMP ( 24.3g),藉由以70°C進行40小時攪拌而使 其溶解。於此溶液中加入NMP(27.1g)、及BCS(26.3g ),藉由以25 °C進行2小時攪拌,得到液晶配向劑[3]。 於此液晶配向劑未見到混濁或析出等異常,確認樹脂成分 均勻地溶解。 使用所得到的液晶配向劑[3 ],與實施例1同樣地製 作液晶胞。結果,液晶爲均勻地垂直配向,未見到配向缺 陷等。且,與實施例1同樣地評估表面自由能量極性項。 © 結果係列示於後述的表2。 &lt;實施例4&gt; 於合成例4所得到的聚醯亞胺粉末(d) (5.0g)中 加入NMP ( 24.2g ),藉由以70°C進行40小時攪拌而使 其溶解。於此溶液中加入NMP(26.〇g)、及BCS (27.5g ),藉由以2 5 °C進行2小時攪拌,得到液晶配向劑[4 ]。 於此液晶配向劑未見到混濁或析出等異常,確認樹脂成分 均勻地溶解。 -51 - 200944553 使用所得到的液晶配向劑[4],與實施例1同樣地製 作液晶胞。結果,液晶爲均勻地垂直配向,未見到配向缺 陷等。且,與實施例1同樣地評估表面自由能量極性項。 結果係列示於後述的表2。 &lt;實施例5&gt; 於合成例5所得到的聚醯亞胺粉末(E ) ( 5.0g )中 加入NMP ( 25.0g ),藉由以70°C進行40小時攪拌而使 _ 其溶解。於此溶液中加入NMP(16.5g)、及BCS(37.1g ),藉由以25t進行2小時攪拌,得到液晶配向劑[5]。 於此液晶配向劑未見到混濁或析出等異常,確認樹脂成分 均勻地溶解。 使用所得到的液晶配向劑[5],與實施例1同樣地製 作液晶胞。結果,液晶爲均勻地垂直配向,未見到配向缺 陷等。且,與實施例1同樣地評估表面自由能量極性項。 結果係列示於後述的表2。 Q &lt;實施例6&gt; 於合成例6所得到的聚醯亞胺粉末(F ) ( 5 · 1 g )中 加入NMP ( 24.5g),藉由以70°C進行40小時攪拌而使 其溶解。於此溶液中加入NMP(28.1g)、及BCS(25.1g )’藉由以25 °C進行2小時攪拌,得到液晶配向劑[6]。 於此液晶配向劑未見到混濁或析出等異常,確認樹脂成分 均勻地溶解。 -52- 200944553 使用所得到的液晶配向劑[6],與實施例1同樣地製 作液晶胞。結果,液晶爲均勻地垂直配向,未見到配向缺 陷等。且,與實施例1同樣地評估表面自由能量極性項。 結果係列示於後述的表2。 • &lt;實施例7&gt; 於合成例7所得到的聚醯亞胺粉末(G ) (5.0g)中 Φ 加入NMP(24.1g),藉由以7(TC進行40小時攪拌而使 其溶解。於此溶液中加入NMP(22.0g)、及BCS(31.5g ),藉由以25 °C進行2小時攪拌,得到液晶配向劑[7]。 於此液晶配向劑未見到混濁或析出等異常,確認樹脂成分 均勻地溶解。 使用所得到的液晶配向劑[7],與實施例1同樣地製 作液晶胞。結果,液晶爲均勻地垂直配向,未見到配向缺 陷等。且,與實施例1同樣地評估表面自由能量極性項。 Θ 結果係列示於後述的表2。 &lt;實施例8&gt; 於合成例8所得到的聚醯亞胺粉末(Η ) ( 5.0 g )中 加入NMP(24.0g),藉由以70 °C進行40小時攪拌而使 其溶解。於此溶液中加入NMP(22.0g)、及BCS(41.1g )’藉由以2 5 °C進行2小時攪拌,得到液晶配向劑[8 ]。 於此液晶配向劑未見到混濁或析出等異常,確認樹脂成分 均勻地溶解。 -53- 200944553 [液晶胞的製作] 將上述所得到的液晶配向劑[8]旋塗佈於附有IT0電 極的玻璃基板,於80 °C的加熱板上使其乾燥5分鐘後’ 以220。(:的熱風循環式烘箱進行15分鐘燒成,製作膜厚 10 Onm的液晶配向膜。將其塗膜面以滾筒徑12〇mm的硏 磨裝置使用嫘縈布,以滾筒旋轉數300rPm、滾筒進行速 度20mm/sec、壓入量0.5mm的條件進行硏磨,得到附有 液晶配向膜的基板。爲了評估液晶胞的配向狀態,準備2 片附有此液晶配向膜的基板,於其1片的液晶配向膜面上 散佈6μηι的間隔物後,於其上印刷密封劑,貼合後、使 密封劑硬化後製作空液晶胞。於此空液晶胞中藉由減壓注 入法,注入液晶 MLC-2003 ( MERCK · JAPAN公司製), 封閉注入口,而得到向列型液晶胞。 以偏光顯微鏡觀察此液晶胞的結果,液晶爲均勻地垂 直配向,未見到配向缺陷等。且,與實施例1同樣地評估 表面自由能量極性項。結果係列示於後述的表2。 &lt;實施例9&gt; 於合成例9所得到的聚醯亞胺粉末(f) (5.1g)中 加入NMP ( 25. lg ) ’藉由以7〇〇c進行4〇小時攪拌而使 其溶解。於此溶液中加入NMP(22.2g)、及BCS(40.9g )’藉由以25 °C進行2小時攪拌,得到液晶配向劑[9]。 於此液晶配向劑未見到混濁或析出等異常,確認樹脂成分 均勻地溶解。 -54- 200944553 使用所得到的液晶配向劑[9],與實施例8同樣地製 作液晶胞。結果,液晶爲均勻地垂直配向,未見到配向缺 陷等。且,與實施例1同樣地評估表面自由能量極性項。 結果係列示於後述的表2。 &lt;比較例1 &gt; 於合成例1 0所得到的聚醯胺酸溶液(J ) ( 1 0.3 g ) 〇 中加入 NMP ( 13.1g )、及 BCS(11.5g),藉由以 25°C 進行2小時攪拌,得到液晶配向劑[1 0]。於此液晶配向劑 未見到混濁或析出等異常,確認樹脂成分均勻地溶解。 使用所得到的液晶配向劑[1 〇],與實施例1同樣地製 作液晶胞。結果,液晶爲均勻地垂直配向,未見到配向缺 陷等。且,與實施例1同樣地評估表面自由能量極性項。 結果係列示於後述的表2。 〇 〈比較例2 &gt; 於合成例1 1所得到的聚醯胺酸溶液(κ) ( 10. 〇g) 中加入 NMP(ll.lg)、及 BCS(13.2g),藉由以 2 5°C . 進行2小時攪拌,得到液晶配向劑[1 1 ]。於此液晶配向劑 未見到混濁或析出等異常,確認樹脂成分均勻地溶解。 使用所得到的液晶配向劑[1 1 ],與實施例1同樣地製 作液晶胞。結果,液晶爲均勻地垂直配向,未見到配向缺 陷等。且,與實施例1同樣地評估表面自由能量極性項。 結果係列示於後述的表2。 -55- 200944553 &lt;比較例3 &gt; 於合成例12所得到的聚醯亞胺粉末(L) (5.1g)中 加入NMP ( 25· 1 g ),藉由以70°C進行40小時攪拌而使 其溶解。於此溶液中加入NMP(17,2g)、及BCS(46.1g ),藉由以25 °C進行2小時攪拌,得到液晶配向劑[12]。 於此液晶配向劑未見到混濁或析出等異常,確認樹脂成分 均勻地溶解。 使用所得到的液晶配向劑[1 2],與實施例1同樣地製 作液晶胞。結果,液晶爲均勻地垂直配向,未見到配向缺 陷等。且,與實施例1同樣地評估表面自由能量極性項。 結果係列示於後述的表2。 再者,表2中,醯亞胺化率項的「-」,係指未算出 醯亞胺化率。 -56- 200944553 [表2] 液晶配向劑 醯亞胺化率 (%) 表面自由能量 極性項 (mN/m) 液晶配向性 實施例1 [1] - 4.3 良好 實施例2 [2] 59 4.0 良好 實施例3 [3] 82 3.5 良好 實施例4 [4] 96 5.9 良好 實施例5 [5] 55 6.7 良好 實施例6 [6] 81 4.5 良好 實施例7 [7] 80 6.6 良好 實施例8 [8] 88 23.0 良好 實施例9 [91 88 23.5 良好 比較例1 [10] 2.3 良好 比較例2 [Π] - 2.2 良好 比較例3 Γ121 79 2.5 良好 [產業上的可利用性] 本發明的液晶配向劑,係可得到可減輕以ODF方式 〇 所發生的液晶配向不均勻之液晶配向膜。因此,具有由藉 此所得到的液晶配向膜之液晶顯示元件,爲可抑制顯示不 均勻,信賴性優異者,可適用於大畫面且高精細的液晶電 視等。結果,適用於TN元件、STN元件、TFT液晶元件 ’更適用於垂直配向型或水平配向型(IPs )的液晶顯示 元件等。 再者,本發明中引用2008年1月25日申請的日本專 利申請案2008_〇 1 53 08號的說明書、申請專利範圍、及摘 要的全部內容’作爲說明書的揭示內容援用於本發明。 -57-Column temperature: 50 °C Dissolution: Ν, Ν '-dimethylformamide (as additive, lithium bromide hydrate (LiBr*H2〇) is 30mmol/L, dish acid. Anhydrous crystal (〇-phosphoric acid) ) is 30 mmol / L, tetrahydrofuran (THF) is 10 ml / L) -39 - 200944553 Flow rate: 1.0 ml / minute calibration line made of standard sample · TSK standard polyethylene oxide manufactured by Tosoh Corporation (molecular weight) 900,000, 150,000, 100,000, 30,000), and Polyethylene glycol (molecular weight of about 12,000, 4,000 '1,000) manufactured by Polymer Laboratories. &lt;Measurement of oxime imidization ratio&gt; The ruthenium imidization ratio of polyimine in the synthesis example was measured by the following procedure. 20 mg of polyimine powder was placed in an NMR sample tube (NMR sampling tube standard φ 5 manufactured by Kusano Scientific Co., Ltd.), and dimethyl sulfoxide (DMSO-d6, 0.05% TMS (tetramethyl decane) was mixed. Product) 0.53ml, the force of the mouth ultrasonic to make it completely dissolved. This solution was measured for proton NMR of 500 MHz using an NMR measuring instrument (JNW-ECA500) manufactured by Nippon Electronics DATUM Co., Ltd. The ruthenium imidization ratio is determined by using protons from the unaltered structure before and after imidization as the reference proton, and the maximum integral enthalpy (integrated value of a peak) of the proton is used, and appears at 9.5 to l〇. The proton maximum integral enthalpy of the NH group derived from valine near ppm is obtained by the following formula.醯 imidization rate (%) = ( 1-α · x / y ) X 1 〇〇 is in the above formula, x is the maximum integral of protons from the NH group of proline, y is the maximum integral 基准 of the reference proton, When α is a poly-proline (the imidization ratio is 0%), the ratio of the protons of the reference 200944553 to one of the ruthenium protons of lysine is proportional to the number of protons. &lt;Synthesis Example 1&gt; BOD A (3 · 7 5 g, 15 mmol), DBA (2.3 g, 15 mmol), and PCH7DAB (3_8 g, 1 mmol) were mixed in NMP (16. 5 g) to 5 After reacting at 0 ° C for 5 hours, CBDA ( 1.96 g, 10 mmol) and NMP (13.0 g) were added, and the reaction was carried out at 40 ° C for 12 hours to obtain a polyaminic acid solution having a resin φ content of 29% by mass. A). The polyamic acid had a number average molecular weight of 22,700 and a weight average molecular weight of 45,100. &lt;Synthesis Example 2&gt; TD A (3.Og, 1 Ommol), DBA (2.3 g, 15 mmo 1 ), and PCH7DAB (3.8 g, 10 mmol) were mixed in NMP (28.8 g) at 5 〇 ° After reacting for 5 hours, CBDA (2.9 g, 15 mmol) and NMP (19. 3 g) were added, and the reaction was carried out at 40 ° C for 12 hours to obtain a poly-proline acid β solution. After adding hydrazine to the polyamic acid solution (20.0 g) and diluting it to 6 mass%, acetic anhydride (2.4 g) and pyridine (1.0 g) as a ruthenium amide catalyst were added at 40 ° C. It reacted for 2 hours. The reaction solution was poured into methanol (250 ml), and the obtained precipitate was filtered. This precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (B). The polyimine had a hydrazide conversion ratio of 59%, a number average molecular weight of 11,700, and a weight average molecular weight of 24,100. -41 - 200944553 &lt;Synthesis Example 3&gt; After the NMP was added to the polyamidic acid solution (20.0 g) obtained in Synthesis Example 2 and diluted to 6 mass%, acetic anhydride (2 _) was added as a ruthenium catalyst. 4 g ) and pyridine (1.0 g) were reacted at 50 ° C for 3 hours. This reaction solution was poured into methanol (250 ml), and the obtained precipitate was filtered. This precipitate was washed with methanol, and dried under reduced pressure at 1 ° C to obtain a polyimine powder (C). The polyimine had an oxime imidization ratio of 82%, a number average molecular weight of 13,600, and a weight average molecular weight of 1,400. &lt;Synthesis Example 4&gt; CBDA (5.0 g, 25 mmol), 2,4-DAA (1.6 g, 8 · 0 mm ο 1 ), DBA (1.2 g, 8.0 mmol), and PCH7DAB (4.0 g, 1) Ommol) was mixed in NMP (47.3 g), and reacted at 23 ° C for 15 hours to obtain a polyaminic acid solution. After adding NMP to the polyamic acid solution (20.0 g) and diluting it to 6 mass%, acetic anhydride (4.3 g) and pyridine (3.3 g) as a ruthenium amide catalyst were added to make 5 (TC) The reaction solution was poured into methanol (260 ml), and the obtained precipitate was filtered, and the precipitate was washed with methanol and dried under reduced pressure at 100 ° C to obtain a polyimine powder (D). The polyamidimide had a ruthenium iodide ratio of 96%, a number average molecular weight of 19,100, and a weight average molecular weight of 45,500. <Synthesis Example 5 &gt; BODA (24.4 g, 1000 mmol), DBA (13.8 g, 9 1 mmol ) 200944553 , and PCH7DAB ( 14.8g, 39mmol) were mixed in NMP (141.6g), and reacted at 80 ° C for 5 hours, then added CBDA (6.0g, 31mmol) and NMP (94.4g), After the reaction was carried out for 12 hours at 401, a polyaminic acid solution was obtained. After the NMP was added to the polyamic acid solution (50. g) to be diluted to 6 mass%, acetic anhydride as a ruthenium catalyst was added ( 5.6 g ) and pyridine (4 · 3 g ) were reacted at 80 ° C for 3 hours. The reaction solution was poured into methanol (600 m 1 ) and filtered. The precipitate obtained was washed with methanol, and dried under reduced pressure at 10 ° C to obtain a polyimine powder (E). The ruthenium imidization ratio of the polyimine was 55%. The average molecular weight was 1,900, and the weight average molecular weight was 62,700. &lt;Synthesis Example 6&gt; BODA (24.4 g, 1000 mmol), DBA (11.9 g, 78 mmol), and PCH7DAB (19. 8 g, 52 mmol) were used in NMP (149. After Og) was mixed and reacted at 80 ° C for 5 hours, CBDA (6.0 g, 31 mmol) and NMP (99.2 g) were added and reacted at 40 ° C for 12 hours to obtain a polyaminic acid solution. After adding NMP to the polyamic acid solution (80.0 g) to dilute to 6 mass%, acetic anhydride (17.9 g) and pyridine (13.8 g) as a ruthenium amide catalyst were added at 90 ° C. The reaction solution was poured into methanol (1 000 ml), and the obtained precipitate was filtered, and the precipitate was washed with methanol and dried under reduced pressure at 100 ° C to obtain a polyimine powder (F). The polyamidimide has an oxime imidization ratio of 81%, a number average molecular weight of -43 to 200944553 20, and a weight average molecular weight of 68,100. &lt;Synthesis Example 7&gt; BODA (24.4 g, 100 mmol), DBA (1 3 · 8 g, 9 1 mm ο 1 ), and PCH7DAB (14.8 g, 39 mmol) were mixed in NMP (141.6 g) to 80 After V was allowed to react for 5 hours, CBDA (6.0 g, 31 mmol) and NMP (94.4 g) were added, and the mixture was reacted at 40 ° C for 12 hours to obtain a polyaminic acid solution. After adding NMP to the polyamic acid solution (50.0 g) and diluting it to 6 mass%, acetic anhydride (11.2 g) and pyridine (8.7 g) which are ruthenium amide catalysts were added, and the mixture was made at 90 °C. Reaction for 3.5 hours. This reaction solution was poured into methanol (600 ml), and the obtained precipitate was filtered. This precipitate was washed with methanol, and dried under reduced pressure at 1 ° C to obtain a polyimine powder (G). The polyimine had an oxime imidization ratio of 80%, a number average molecular weight of 1,500, and a weight average molecular weight of 62,200. &lt;Synthesis Example 8&gt; TDA (1 2.0 g, 40 mm ο 1 ), DBA (3.0 g, 20 mmol), and p-PDA (2.2 g, 20 mmol) were mixed in NMP (68.8 g) to 5 0 The reaction was allowed to proceed for 15 hours at ° C to obtain a polyaminic acid solution. After adding NMP to the polyamic acid solution (50. Og) and diluting it to 6% by mass, acetic anhydride (2 3 · 7 g ) as a ruthenium amide catalyst and pyridine (1 1.0 g ) were added to The reaction was allowed to proceed at 50 ° C for 3 hours. This reaction solution was poured into methanol (8 2 0 m 1 ), and the obtained precipitate was filtered. This precipitate 200944553 was washed with methanol, and dried under reduced pressure at 1 ° C to obtain a polyimine powder (Η). The polyamidimide had a ruthenium iodide ratio of 88%, a number average molecular weight of 17,700, and a weight average molecular weight of 65,700. &lt;Synthesis Example 9&gt; TD A (6.0 g, 20 mm ο 1 ), DB A (1.5 g, 10 mm ο 1 ), and DADPA (2.0 g, 10 mmol) were mixed in NMP (38.1 g). The reaction was carried out at 50 φ ° C for 15 hours to obtain a polyaminic acid solution. After adding NMP to the polyamic acid solution (30.0 g) and diluting it to 6% by mass, acetic anhydride (12.9 g) and pyridine (6.0 g) as a ruthenium amide catalyst were added thereto, and the mixture was added at 50 ° C at 50 ° C. Reaction for 3 hours. The reaction solution was poured into methanol (500 ml), and the obtained precipitate was filtered. This precipitate was washed with methanol, and dried under reduced pressure at 1 ° C to obtain a polyimine powder (1). The polyimine has a ruthenium iodide ratio of 88%, a number average molecular weight of 18,000, and a weight average molecular weight of 72,900. ❹ &lt;Synthesis Example 1 〇&gt; CBD A (3.0 g, 16 mmol), p-PD A (0.9 g, 8 mmο 1 ), and PCH7DAB (3.0 g, 8 mmol) were mixed in NMP (39.4 g) to The mixture was reacted at 2 ° C for 20 hours to obtain a polyaminic acid solution (J) having a resin content of 15% by mass. This polyamic acid had a number average molecular weight of 27,000 and a weight average molecular weight of 63,000. <Synthesis Example 11&gt; -45- 200944553 PMDA (2.6 g, 12 mmol), p-PDA (0.7 g, 6 mmol), and PCH7DAB (2.3 g, 6 mmol) were mixed in NMP (32.0 g) to 2 3 ° C was allowed to react for 20 hours to obtain a polyaminic acid solution (K) having a resin content of 15% by mass. The polyamic acid had a number average molecular weight of 28,300 and a weight average molecular weight of 71,200. &lt;Synthesis Example 1 2 &gt; TD A (3 · 1 g, 1 Ommol ) , m-PD A (1 · 7 g, 16 mmo 1 ), and PCH7DAB (4. 〇g, l〇mm〇l) After mixing in NMP (28.4 g) and reacting at 50 ° C for 5 hours, CBDA (3.0 g, 16 mmol) and NMP (18_9 g) were added, and reacted at 40 ° C for 12 hours to obtain polylysine. Solution. After adding NMP to the polyamic acid solution (20.0 g) and diluting it to 6 mass%, acetic anhydride (2.6 g) as a ruthenium amide catalyst and pyridine (1.1 g) were added to 5 (TC). The reaction solution was allowed to react for 3 hours, and the reaction solution was poured into methanol (250 ml), and the obtained precipitate was filtered, and the precipitate was washed with methanol, and dried under reduced pressure to give a polyimine. Powder (L). The polyimine has a hydrazide conversion ratio of 79%, a number average molecular weight of 12,000, and a weight average molecular weight of 27,900. 200944553 [Table i] Synthesis Example Tetracarboxylic dianhydride (mmol) Diamine Compound (mmol) Ruthenium amination rate (%) Specific acid dianhydride Other acid dianhydride Specific diamine Other diamine 1 Polylysine (A) CBDA (10) BODA (15) - DBA (15) PCH7DAB ( 10) - 2 Polyimine powder (B) TDA(IO) CBDA(15) - DBA(15) PCH7DAB(10) 59 3 Polyimine powder (C) TDA(IO) CBDA(15) - DBA( 15) PCH7DAB(10) 82 4 Polyimine powder (D) CBDA(25) - DBA(8) PCH7DAB(10) 2,4-DAA(8) 96 5 Polyimine powder (6) CBDA(31) BODA (IOO) - DBA(91) PCH7DAB(39) 55 6 Polyimine powder (F) CBDA(31) BODA(100O) - DBA(78) PCH7DAB(52) 81 7 Polyimine powder (G) CBDA(31) BODA(100O) - DBA(91) PCH7DAB(39) 80 8 Polyimine powder (H) TDA(40) - DBA(20) p-PDA(20) 88 9 Polyimine powder (I) TDA(20) - DBA(10) DADPA(IO) 88 10 Poly-proline (J) CBDA (16 ) - - p-PDA (8) PCH7DAB(8) - 11 Poly-proline (K) - PMDA(12) - p-PDA (6) PCH7DAB(6) - 12 Polyimide powder (L) TDA(10) CBDA( 16) - - m-PDA(16) PCH7DAB(10) 79 -47- 200944553 The column of 'tetracarboxylic dianhydride' in the table and the "-" in the block of "diamine compound" indicate that This acid dianhydride and a specific diamine were used. &lt;Example 1&gt; In the polyaminic acid solution (A) (10.Og) obtained in Synthesis Example 1, NMP (12.5 g) and BCS (25.5 g) were added. The liquid crystal alignment agent [i] was obtained by stirring at 251: for 2 hours. No abnormality such as turbidity or precipitation was observed in the liquid crystal alignment agent, and it was confirmed that the resin component was uniformly dissolved. ❹ [Production of liquid crystal cell] The liquid crystal alignment agent [1] obtained above was spin-coated on a glass substrate with an ITO electrode, and dried on a hot plate at 80 ° C for 5 minutes, and then at 220 ° C. The hot air circulating oven was fired for 15 minutes to prepare a liquid crystal alignment film having a film thickness of 100 nm. Two sheets of the substrate having the liquid crystal alignment film were prepared, and a spacer of 6 μm was spread on one of the liquid crystal alignment film surfaces, and then a sealant was printed thereon, and after bonding, the sealant was cured to prepare an empty liquid crystal cell. . In this empty liquid crystal cell, liquid crystal ML C-66 0 8 (manufactured by MERCK. JAPAN Co., Ltd.) was injected by a reduced pressure injection method, and the injection port was closed to obtain a nematic liquid crystal cell. As a result of observing the liquid crystal cell by a polarizing microscope, the liquid crystal was uniformly aligned vertically, and no alignment defect was observed. [Evaluation of Surface Free Energy Polarity Term] In the present invention, the surface of the liquid crystal alignment film is easily adsorbed with adsorbed water or impurities. When the liquid crystal is dropped in the ODF step, the adsorbed water or impurities adhering to the surface of the liquid crystal alignment film are suppressed. The concentrated evaluation method focuses on the surface free energy polarity term of the liquid crystal alignment film. The greater the recovery, the higher the effect. The liquid crystal alignment agent [1] obtained above was spin-coated on a glass substrate with an ITO electrode, dried on a hot plate at 80 ° C for 5 minutes, and then subjected to a hot air circulating oven at 220 ° C for 15 minutes. The film was fired to prepare a liquid crystal alignment film having a film thickness of 100 nm. The contact angle of pure water with diiodomethane was measured using a substrate with this liquid crystal alignment film. Using these contact angles, the surface free energy (also called surface tension) is calculated according to the method of DKOWΕΝS et al., as described in the literature [JOURNAL OF APPLIED POLYMER SCIENCE VOL. 13, pp. 1741-1747 (1969)]. Polarity term. (l+COS0)xyL = 2(YSdxYLd)l/2 + 2(YSpxyLp)l/2 Equation [i] • where yL=yLd+yLp ' YS=ySd+YSp θ: contact angle of the liquid on the coating film Γί: surface free energy of liquid YLd: surface free energy dispersion of liquid yLP: surface free energy polarity of liquid ys: surface free energy of coating film ysd: surface free energy dispersion of coating film ySp: surface freedom of coating film Energy polarity term -49- 200944553 Moreover, the surface tension of water at 20 °C (7L = 72.8, r Ld = 21.8 ' r Lp = 5 1 .0 ) ( mPa s ) and the surface tension of diiodomethane (r L = 50.8, γ Ld = 49.5 &gt; r Lp = l .3 ) (mPa-s) Substituting into the formula [i], the following formula [ii] is obtained in the case of pure water, and the formula [iii] is obtained in the case of diiodomethane. ]. Among them, 01 and 02 are each a contact angle of water with diiodomethane (CH2I2). (l+COS0 1)x72.8 = 2(YSdx2 1.8)l/2 + 2(ySpx5 1.O)l/2 Equation [ii] (l+COS02)x5O.8 = 2(YSdx49.5)l/ 2 + 2(ySpx 1.3) 1/2 Formula [iii] Therefore, the contact angles of pure water and diiodomethane are substituted in the formula [ii] and the formula [iii], and the rsP is obtained by the cubic equation. Further, the contact angle was measured by using a contact angle measuring device CA-W (manufactured by Kyowa Interface Chemical Co., Ltd.), and water 3//1, diiodomethane 1#1 was dropped on the coating film, and the contact angle after 5 seconds was measured. And ask for it. The result series is shown in Table 2 below. <Example 2> NMP (24. NMP (12.3 g) and BCS (41.5 g) were added to the solution, and the mixture was stirred at 25 ° C for 2 hours to obtain a liquid crystal alignment agent [2]. No abnormality such as turbidity or precipitation was observed in the liquid crystal alignment agent, and it was confirmed that the resin component was uniformly dissolved. -50-200944553 A liquid crystal cell was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent [2]. As a result, the liquid crystal was uniformly aligned vertically, no alignment defects were observed, and the surface free energy polarity term was evaluated in the same manner as in the first embodiment. The result series is shown in Table 2 which will be described later. &lt;Example 3&gt; In the polyimine powder (C) (5 · 1 g) obtained in Synthesis Example 3, NMP (24. 3 g) was added and Φ was stirred at 70 ° C for 40 hours. Dissolved. NMP (27.1 g) and BCS (26.3 g) were added to the solution, and the mixture was stirred at 25 ° C for 2 hours to obtain a liquid crystal alignment agent [3]. No abnormality such as turbidity or precipitation was observed in the liquid crystal alignment agent, and it was confirmed that the resin component was uniformly dissolved. Using the obtained liquid crystal alignment agent [3], a liquid crystal cell was produced in the same manner as in Example 1. As a result, the liquid crystal was uniformly aligned vertically, and no alignment defect or the like was observed. Further, the surface free energy polarity term was evaluated in the same manner as in the first embodiment. © The result series is shown in Table 2 below. <Example 4> NMP (24. NMP (26. g) and BCS (27.5 g) were added to the solution, and the mixture was stirred at 25 ° C for 2 hours to obtain a liquid crystal alignment agent [4]. No abnormality such as turbidity or precipitation was observed in the liquid crystal alignment agent, and it was confirmed that the resin component was uniformly dissolved. -51 - 200944553 A liquid crystal cell was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent [4]. As a result, the liquid crystal was uniformly aligned vertically, and no alignment defect or the like was observed. Further, the surface free energy polarity term was evaluated in the same manner as in the first embodiment. The result series is shown in Table 2 which will be described later. &lt;Example 5&gt; NMP (25.0 g) was added to the polyimine powder (E) (5.0 g) obtained in Synthesis Example 5, and the mixture was dissolved by stirring at 70 ° C for 40 hours. NMP (16.5 g) and BCS (37.1 g) were added to the solution, and the mixture was stirred at 25 t for 2 hours to obtain a liquid crystal alignment agent [5]. No abnormality such as turbidity or precipitation was observed in the liquid crystal alignment agent, and it was confirmed that the resin component was uniformly dissolved. Using the obtained liquid crystal alignment agent [5], a liquid crystal cell was produced in the same manner as in Example 1. As a result, the liquid crystal was uniformly aligned vertically, and no alignment defect or the like was observed. Further, the surface free energy polarity term was evaluated in the same manner as in the first embodiment. The result series is shown in Table 2 which will be described later. Q &lt;Example 6&gt; NMP (24.5 g) was added to the polyimine powder (F) (5 · 1 g) obtained in Synthesis Example 6, and dissolved by stirring at 70 ° C for 40 hours. . NMP (28.1 g) and BCS (25.1 g) were added to the solution to obtain a liquid crystal alignment agent [6] by stirring at 25 ° C for 2 hours. No abnormality such as turbidity or precipitation was observed in the liquid crystal alignment agent, and it was confirmed that the resin component was uniformly dissolved. -52- 200944553 A liquid crystal cell was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent [6]. As a result, the liquid crystal was uniformly aligned vertically, and no alignment defect or the like was observed. Further, the surface free energy polarity term was evaluated in the same manner as in the first embodiment. The result series is shown in Table 2 which will be described later. &lt;Example 7&gt; In the polyimine powder (G) (5.0 g) obtained in Synthesis Example 7, Φ was added to NMP (24.1 g), and the mixture was dissolved by stirring at 7 (TC) for 40 hours. NMP (22.0 g) and BCS (31.5 g) were added to the solution, and the liquid crystal alignment agent [7] was obtained by stirring at 25 ° C for 2 hours. No abnormality such as turbidity or precipitation was observed in the liquid crystal alignment agent. The resin component was uniformly dissolved. The liquid crystal cell was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent [7]. As a result, the liquid crystal was uniformly aligned vertically, and no alignment defect or the like was observed. 1 The surface free energy polarity term was evaluated in the same manner. Θ The results are shown in Table 2 to be described later. <Example 8> NMP (24.0) was added to the polyimine powder (Η) (5.0 g) obtained in Synthesis Example 8. g), dissolved by stirring at 70 ° C for 40 hours, and NMP (22.0 g) and BCS (41.1 g ) were added to the solution to obtain a liquid crystal by stirring at 25 ° C for 2 hours. The alignment agent [8]. No abnormality such as turbidity or precipitation was observed in the liquid crystal alignment agent, and it was confirmed that the resin component was uniformly dissolved. -53- 20094 4553 [Production of liquid crystal cell] The liquid crystal alignment agent [8] obtained above was spin-coated on a glass substrate with an IT0 electrode, and dried on a hot plate at 80 ° C for 5 minutes, then '220. The hot air circulation type oven was fired for 15 minutes to produce a liquid crystal alignment film having a film thickness of 10 Onm. The coating surface was made of a honing device having a drum diameter of 12 mm, and the number of rotations of the drum was 300 rPm, and the speed of the drum was used. 20 mm/sec and a press-in amount of 0.5 mm were honed to obtain a substrate with a liquid crystal alignment film. In order to evaluate the alignment state of the liquid crystal cells, two substrates having the liquid crystal alignment film were prepared, and one liquid crystal was attached thereto. After dispersing a spacer of 6 μm on the alignment film surface, a sealant is printed thereon, and after bonding, the sealant is cured to prepare an empty liquid crystal cell. In this empty liquid crystal cell, liquid crystal MLC-2003 is injected by a vacuum injection method. (manufactured by MERCK JAPAN Co., Ltd.), the inlet cell was closed to obtain a nematic liquid crystal cell. As a result of observing the liquid crystal cell by a polarizing microscope, the liquid crystal was uniformly aligned vertically, and no alignment defect or the like was observed. Similarly to evaluate the surface From the energy polarity term, the results are shown in Table 2 to be described later. <Example 9> NMP ( 25. lg ) was added to the polyimine powder (f) (5.1 g) obtained in Synthesis Example 9 by The solution was dissolved by stirring at 7 ° C for 4 hours, and NMP (22.2 g) and BCS (40.9 g ) were added to the solution to obtain a liquid crystal alignment agent by stirring at 25 ° C for 2 hours. ]. No abnormality such as turbidity or precipitation was observed in the liquid crystal alignment agent, and it was confirmed that the resin component was uniformly dissolved. -54- 200944553 A liquid crystal cell was produced in the same manner as in Example 8 using the obtained liquid crystal alignment agent [9]. As a result, the liquid crystal was uniformly aligned vertically, and no alignment defect or the like was observed. Further, the surface free energy polarity term was evaluated in the same manner as in the first embodiment. The result series is shown in Table 2 which will be described later. &lt;Comparative Example 1 &gt; NMP (1. 13 g) and BCS (11.5 g) were added to the poly (protonic acid) solution (J) (1 0.3 g) obtained in Synthesis Example 10 by 25 ° C The mixture was stirred for 2 hours to obtain a liquid crystal alignment agent [1 0]. In the liquid crystal alignment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed that the resin component was uniformly dissolved. Using the obtained liquid crystal alignment agent [1 〇], a liquid crystal cell was produced in the same manner as in Example 1. As a result, the liquid crystal was uniformly aligned vertically, and no alignment defect or the like was observed. Further, the surface free energy polarity term was evaluated in the same manner as in the first embodiment. The result series is shown in Table 2 which will be described later. 〇 <Comparative Example 2 &gt; NMP (ll.lg) and BCS (13.2 g) were added to the polyaminic acid solution (κ) (10 〇g) obtained in Synthesis Example 1 1 by using 2 5 °C. Stirring was carried out for 2 hours to obtain a liquid crystal alignment agent [1 1 ]. In the liquid crystal alignment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed that the resin component was uniformly dissolved. Using the obtained liquid crystal alignment agent [1 1 ], a liquid crystal cell was produced in the same manner as in Example 1. As a result, the liquid crystal was uniformly aligned vertically, and no alignment defect or the like was observed. Further, the surface free energy polarity term was evaluated in the same manner as in the first embodiment. The result series is shown in Table 2 which will be described later. -55-200944553 &lt;Comparative Example 3 &gt; NMP (25·1 g) was added to the polyimine powder (L) (5.1 g) obtained in Synthesis Example 12, and stirred at 70 ° C for 40 hours. And let it dissolve. NMP (17, 2 g) and BCS (46.1 g) were added to the solution, and the mixture was stirred at 25 ° C for 2 hours to obtain a liquid crystal alignment agent [12]. No abnormality such as turbidity or precipitation was observed in the liquid crystal alignment agent, and it was confirmed that the resin component was uniformly dissolved. A liquid crystal cell was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent [1 2]. As a result, the liquid crystal was uniformly aligned vertically, and no alignment defect or the like was observed. Further, the surface free energy polarity term was evaluated in the same manner as in the first embodiment. The result series is shown in Table 2 which will be described later. In addition, in Table 2, the "-" of the ruthenium iodization rate means that the ruthenium imidization ratio is not calculated. -56- 200944553 [Table 2] Liquid crystal alignment agent 醯 imidization ratio (%) Surface free energy polarity term (mN/m) Liquid crystal alignment Example 1 [1] - 4.3 Good Example 2 [2] 59 4.0 Good Example 3 [3] 82 3.5 Good Example 4 [4] 96 5.9 Good Example 5 [5] 55 6.7 Good Example 6 [6] 81 4.5 Good Example 7 [7] 80 6.6 Good Example 8 [8 88 23.0 Good Example 9 [91 88 23.5 Good Comparative Example 1 [10] 2.3 Good Comparative Example 2 [Π] - 2.2 Good Comparative Example 3 Γ121 79 2.5 Good [Industrial Applicability] Liquid Crystal Aligning Agent of the Present Invention A liquid crystal alignment film which can reduce the unevenness of liquid crystal alignment which occurs in the ODF method can be obtained. Therefore, the liquid crystal display element having the liquid crystal alignment film obtained therefrom can be applied to a large-screen, high-definition liquid crystal television or the like in order to suppress display unevenness and excellent reliability. As a result, it is suitable for a liquid crystal display element such as a TN element, an STN element, or a TFT liquid crystal element, which is more suitable for vertical alignment type or horizontal alignment type (IPs). In addition, in the present invention, the specification, the scope of the patent application, and the summary of the Japanese Patent Application No. 2008-A No. -57-

Claims (1)

200944553 七、申請專利範圍: 1· 一種液晶配向劑,其特徵係含有使含有下述式π] 所表示的四羧酸二酐之四羧酸二酐成分、與含有分子內具 有羧基或羥基的二胺化合物之二胺成分進行反應而得到的 聚合物, [化1]200944553 VII. Patent application scope: 1. A liquid crystal alignment agent characterized by containing a tetracarboxylic dianhydride component containing a tetracarboxylic dianhydride represented by the following formula π] and having a carboxyl group or a hydroxyl group in the molecule. a polymer obtained by reacting a diamine component of a diamine compound, [Chemical Formula 1] [1] ❹ (式[1]中,Y!係具有碳數4至8的非芳香族環狀結構之 碳數4至15的4價的有機基)。 2.如申請專利範圍第1項之液晶配向劑’其係式[1 ] 中,Υι爲由下述式[2]至式Π丨]所選出的基’[1] ❹ (In the formula [1], Y! is a tetravalent organic group having 4 to 15 carbon atoms in a non-aromatic cyclic structure having 4 to 8 carbon atoms). 2. In the liquid crystal alignment agent of the first aspect of the patent application, in the formula [1], Υι is a base selected by the following formula [2] to the formula ’] 介允 ΙΤΣ XXrC Ο [4]ΙΤΣ XX XXrC Ο [4] [5][5] [6] C7][6] C7] [8] [9] (式[2]中,Y2至丫5各自獨立地爲由氫原子、甲基、氯原 子及苯環所選出的基,各自可相同或相異;式[8]中’ Υ6 -58- 200944553 、Y7各自獨立地爲氫原子、或甲基,各自可相同或相異} 〇 3 ·如申請專利範圍第2項之液晶配向劑,其中式[1 ] 中,Υι爲式[2] » 4.如申請專利範圍第2項之液晶配向劑,其中式[1 ] 中,Υι爲式[4]。 5 .如申請專利範圍第2項之液晶配向劑,其中式Π ] 〇 中’ Υι爲式[5]。 6. 如申請專利範圍第2項之液晶配向劑,其中式[1 ] 中,Υι爲式[7]。 7. 如申請專利範圍第2項之液晶配向劑,其中式[1 ] 中,Υι爲式[8]。 8 ·如申請專利範圍第1至7項中任一項之液晶配向 劑’其中具有羧基之二胺化合物,爲下述式[12]所表示的 二胺化合物, ❹ [化3] (?00Η)η 1 [12] Η#,、Η2 (式[12]中’ Χι係具有碳數6至30的芳香族環之有機基 ’ η爲1至4的整數)。 9.如申請專利範圍第8項之液晶配向劑,其中式 [12]的二胺化合物’係由下述式3]至式[17]所選出的二 胺化合物, -59- 200944553 [化4][8] [9] (In the formula [2], Y2 to 丫5 are each independently selected from a hydrogen atom, a methyl group, a chlorine atom and a benzene ring, and each may be the same or different; in the formula [8] ' Υ6 -58- 200944553, Y7 are each independently a hydrogen atom or a methyl group, each of which may be the same or different} 〇3 · As in the liquid crystal alignment agent of claim 2, in the formula [1], Υι is [2] » 4. The liquid crystal alignment agent of claim 2, wherein in the formula [1], Υι is the formula [4]. 5. The liquid crystal alignment agent of claim 2, wherein ] 〇中' Υι is the formula [5]. 6. For the liquid crystal alignment agent of the second paragraph of the patent application, in the formula [1], Υι is the formula [7]. 7. The liquid crystal according to the second item of the patent application In the formula [1], Υι is a formula [8]. The liquid crystal alignment agent of any one of the above claims 1 to 7 wherein the diamine compound having a carboxyl group is the following formula [ 12] The diamine compound represented by ❹ [Chemical 3] (?00Η)η 1 [12] Η#,, Η2 (In the formula [12], Χι is an organic group having an aromatic ring having 6 to 30 carbon atoms. 'η is 1 to 4 9. The liquid crystal alignment agent of claim 8, wherein the diamine compound of the formula [12] is a diamine compound selected from the following formula 3] to the formula [17], -59-200944553 [ 4] (CH2)meCOOH H2N(CH2)meCOOH H2N (CH2)m4C00H cH2)m5C〇〇H [15] h2n-(CH2)m4C00H cH2)m5C〇〇H [15] h2n- ιΌ^Η2 Η2Ν0^0^0^Η2 L (b〇〇H)m7 [17] [16]ΌΌ^Η2 Η2Ν0^0^0^Η2 L (b〇〇H)m7 [17] [16] 式[13]中,ml爲1至4的整數;式[14]中,X2爲單鍵、-ch2-、-c2h4-、-c(ch3)2-、-cf2_、-c(cf3)2-、-o-、-co-、-nh-、-n(ch3)-、-conh-、-nhco-、-ch2o-、-och2-、-COO-、-OCO-、-C0N(CH3)-或-N(CH3)C0-,m2 及 m3 各自表示〇至4的整數,且m2 + m3表示1至4的整數; 式[15]中,m4及m5各自爲1至5的整數;式[16]中,X3 爲碳數1至5的直鏈或支鏈烷基,m6爲1至5的整數; 式[17]中,X4 爲單鍵、-&lt;:112-、-(:2114-、-(:((:113)2-、-〇?2-、-C(CF3)2-、-0-、-C0-、-NH-'-N(CH3)-、-C0NH-、- nhco-、-ch2o-、-och2-、-coo-、-oco-、-con(ch3)- 或-N(CH3)CO-,m7爲1至4的整數)。 10.如申請專利範圍第9項之液晶配向劑,其中式 [13] 中,ml爲1至2的整數。 1 1 .如申請專利範圍第9項之液晶配向劑,其中式 [14] 中,X2 爲單鍵、-CH2-、-C2H4-、-C(CH3)2-、-0- ' -CO-、-NH- ' -N(CH3)-、-CONH-、-NHCO-、-COO-或-OCO-,m2及m3皆爲1的整數。 -60- 200944553 12.如申請專利範圍9項之液晶配向劑,其中式[1 7] 中,X4 爲單鍵、-(:112-、-〇-、-(:0-、-:^11-、-(:0&gt;^11-、-NHCO·、-CH20-、-OCH2-、-COO-或-OCO-,m7 爲 1 至 2 的整數。 * 1 3.如申請專利範圍第丨至〗2項中任一項所記載之 - 液晶配向劑,其中具有羧基或羥基之二胺化合物,爲二胺 成分中的5至100莫耳%。 0 14.如申請專利範圍第1至1 3項中任一項之液晶配 向劑,其中液晶配向劑所含有的溶劑中之5至80質量% 爲弱溶劑。 1 5 _如申請專利範圍第1至1 4項中任一項之液晶配 向劑’其中液晶配向劑中之聚合物係使聚醯胺酸進行脫水 閉環而得到的聚醯亞胺。 16· —種液晶配向膜,其特徵係使用申請專利範圍第 1至1 5項中任一項所記載之液晶配向劑而得到。 〇 1 7. —種液晶顯示元件,其特徵係具有申請專利範圍 第1 6項之液晶配向膜。 -61 - 200944553 四、指定代表圖: (一) 本案指定代表圖為:無。 (二) 本代表圖之元件符號簡單說明:無In the formula [13], ml is an integer of 1 to 4; in the formula [14], X2 is a single bond, -ch2-, -c2h4-, -c(ch3)2-, -cf2_, -c(cf3)2 -, -o-, -co-, -nh-, -n(ch3)-, -conh-, -nhco-, -ch2o-, -och2-, -COO-, -OCO-, -C0N(CH3) - or -N(CH3)C0-, m2 and m3 each represent an integer of 〇4, and m2 + m3 represents an integer of 1 to 4; in the formula [15], m4 and m5 are each an integer of 1 to 5; In [16], X3 is a linear or branched alkyl group having 1 to 5 carbon atoms, and m6 is an integer of 1 to 5; in the formula [17], X4 is a single bond, -&lt;: 112-, -(: 2114-, -(:((:113)2-, -〇?2-, -C(CF3)2-,-0-, -C0-, -NH-'-N(CH3)-, -C0NH- , -nhco-, -ch2o-, -och2-, -coo-, -oco-, -con(ch3)- or -N(CH3)CO-, m7 is an integer from 1 to 4.) The liquid crystal alignment agent of the ninth aspect, wherein in the formula [13], ml is an integer of 1 to 2. 1 1. The liquid crystal alignment agent of claim 9, wherein in the formula [14], X2 is a single bond. , -CH2-, -C2H4-, -C(CH3)2-, -0- '-CO-, -NH- '-N(CH3)-, -CONH-, -NHCO-, -COO- or -OCO -, m2 and m3 are all integers of 1. -60- 200944553 12.If applying A liquid crystal alignment agent having a range of 9 items, wherein in the formula [1 7], X4 is a single bond, -(:112-, -〇-, -(:0-, -:^11-, -(:0&gt;^ 11-, -NHCO·, -CH20-, -OCH2-, -COO- or -OCO-, m7 is an integer from 1 to 2. * 1 3. As in any of the scope of claims 2 to 2 The liquid crystal alignment agent, wherein the diamine compound having a carboxyl group or a hydroxyl group is from 5 to 100 mol% in the diamine component. 0. The liquid crystal alignment according to any one of claims 1 to 13. The liquid crystal alignment agent of any one of the liquid crystal alignment agents of any one of claims 1 to 4, wherein the liquid crystal alignment agent is polymerized in the liquid crystal alignment agent, wherein 5 to 80% by mass of the solvent contained in the liquid crystal alignment agent is a weak solvent. A polyimine obtained by dehydration ring-closing of a poly-proline. The liquid crystal alignment film is characterized by using the liquid crystal alignment agent according to any one of claims 1 to 15. 〇1 7. A liquid crystal display element characterized by having a liquid crystal alignment film of claim 16 of the patent application. -61 - 200944553 IV. Designated representative map: (1) The representative representative of the case is: None. (2) A brief description of the symbol of the representative figure: none -3- 200944553 五、本案若有化學式時,請揭示最能顯示發明特徵的化學式:-3- 200944553 V. If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention:
TW98103105A 2008-01-25 2009-01-23 Liquid crystal aligning agent, and liquid crystal display element TWI444407B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008015308 2008-01-25

Publications (2)

Publication Number Publication Date
TW200944553A true TW200944553A (en) 2009-11-01
TWI444407B TWI444407B (en) 2014-07-11

Family

ID=40901214

Family Applications (1)

Application Number Title Priority Date Filing Date
TW98103105A TWI444407B (en) 2008-01-25 2009-01-23 Liquid crystal aligning agent, and liquid crystal display element

Country Status (5)

Country Link
JP (1) JP5651953B2 (en)
KR (1) KR101589320B1 (en)
CN (1) CN101925851B (en)
TW (1) TWI444407B (en)
WO (1) WO2009093711A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI485201B (en) * 2012-08-10 2015-05-21 Nissan Chemical Ind Ltd Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
TWI617622B (en) * 2013-02-28 2018-03-11 Nissan Chemical Ind Ltd Liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element
TWI621662B (en) * 2012-08-21 2018-04-21 Jsr股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105754098B (en) * 2010-10-06 2018-05-18 株式会社日本显示器 Composition for forming alignment film
US8886106B2 (en) * 2011-03-02 2014-11-11 Konica Minolta Business Technologies, Inc. Intermediate transfer belt and method for producing the same
JP5292438B2 (en) * 2011-05-23 2013-09-18 株式会社ジャパンディスプレイ Liquid crystal display
KR102224531B1 (en) * 2011-09-08 2021-03-05 닛산 가가쿠 가부시키가이샤 Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
KR101515527B1 (en) 2012-08-21 2015-04-27 주식회사 엘지화학 Optical anistropic film
TWI508998B (en) * 2012-10-03 2015-11-21 Chi Mei Corp Liquid crystal aligning agent and its application
KR102135493B1 (en) * 2013-05-01 2020-08-26 닛산 가가쿠 가부시키가이샤 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
KR101861067B1 (en) * 2013-08-30 2018-05-28 동우 화인켐 주식회사 Black photosensitive resin composition
CN110590798A (en) * 2014-01-17 2019-12-20 日产化学工业株式会社 Process for producing cyclobutanetetracarboxylic acid derivative
WO2018025872A1 (en) * 2016-08-03 2018-02-08 日産化学工業株式会社 Liquid crystal display element equipped with liquid crystal panel having curved surface and liquid crystal aligning agent for same
KR102097811B1 (en) * 2017-07-27 2020-04-07 주식회사 엘지화학 Preparation Method for Optical Device
KR20200058281A (en) * 2018-11-19 2020-05-27 제이엔씨 주식회사 Liquid crystal aligning agents for forming liquid crystal alignment films, liquid crystal alignment films and liquid crystal display devices using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2691212B2 (en) * 1989-08-10 1997-12-17 日本合成ゴム株式会社 Liquid crystal alignment agent
JPH03261915A (en) * 1990-03-13 1991-11-21 Japan Synthetic Rubber Co Ltd Liquid crystal orienting agent
JPH07309351A (en) * 1994-05-17 1995-11-28 Idemitsu Petrochem Co Ltd Bag with fastener
JP4171851B2 (en) 1997-12-02 2008-10-29 日産化学工業株式会社 Liquid crystal alignment treatment agent
KR100734933B1 (en) * 2001-06-12 2007-07-03 한라공조주식회사 Method for controlling cooling starting of full automatic temperature control type air-conditioner
JP2005097377A (en) * 2003-09-24 2005-04-14 Fuji Photo Film Co Ltd Alignment layer, polymer, retardation plate using it, its preparing method and liquid crystal display device

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI485201B (en) * 2012-08-10 2015-05-21 Nissan Chemical Ind Ltd Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
TWI621662B (en) * 2012-08-21 2018-04-21 Jsr股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI617622B (en) * 2013-02-28 2018-03-11 Nissan Chemical Ind Ltd Liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element

Also Published As

Publication number Publication date
CN101925851B (en) 2013-09-25
WO2009093711A1 (en) 2009-07-30
JPWO2009093711A1 (en) 2011-05-26
TWI444407B (en) 2014-07-11
KR20100103550A (en) 2010-09-27
JP5651953B2 (en) 2015-01-14
KR101589320B1 (en) 2016-01-27
CN101925851A (en) 2010-12-22

Similar Documents

Publication Publication Date Title
TWI444407B (en) Liquid crystal aligning agent, and liquid crystal display element
TWI486380B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
JP5904121B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP5387793B2 (en) Liquid crystal alignment agent
KR101397294B1 (en) Liquid crystal aligning agent, liquid crystal alignment film using the same, and liquid crystal display element
JP5729299B2 (en) Diamine compound, polyamic acid, polyimide and liquid crystal alignment treatment agent
KR101613751B1 (en) Liquid crystal aligning agent and liquid crystal display element using same
JP5663876B2 (en) Liquid crystal aligning agent and liquid crystal display element using the same
JP6233309B2 (en) Liquid crystal aligning agent, liquid crystal aligning film, and liquid crystal display element
WO2009093709A1 (en) Liquid-crystal alignment material, liquid-crystal alignment film, and liquid-crystal display element
JP7027890B2 (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
WO2012147939A1 (en) Polyimide precursor modified with dicarboxylic acid anhydride, and imidized polyimide and liquid crystal alignment treatment agent comprising same
TWI520984B (en) Liquid crystal alignment film and a liquid crystal display element to the processing agent, with the liquid crystal
JP6065074B2 (en) Diamine compounds, polyimide precursors and polyimides
TWI633128B (en) Composition, liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
JP6183616B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
CN109791332B (en) Liquid crystal display element having curved liquid crystal panel and liquid crystal aligning agent used for same
TW201030058A (en) Liquid crystal aligning agent and liquid crystal element using same
TWI494374B (en) A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device using the same
CN115368914A (en) Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element